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Abstract in English 
Background: Anxiety disorders are highly comorbid with other mental disorders. This has important 
implications for individuals’ burden, etiology of the comorbid diseases and treatment. Knowledge about 
the comorbidity with physical diseases in the community, however, is limited, especially for specific 
anxiety disorders. This dissertation evaluates the comorbidity of specific anxiety disorders and 
noncommunicable and communicable physical diseases in the general population. Further, it investigates 
the association of comorbidity with measures of burden, namely, quality of life and disability. 
 
Method: Data of the German Health Interview and Examination Survey (GHS), a representative general 
population survey from Germany with 4,181 subjects aged 18-65 years, were used. Anxiety disorders 
were diagnosed using the Munich-Composite International Diagnostic Interview (DIA-X/M-CIDI), 
noncommunicable physical diseases were assessed through a self-report questionnaire and a 
standardized medical interview, and communicable physical diseases through a self-report questionnaire. 
 
Results: Both obsessive-compulsive disorder (OCD) and specific phobia were associated with migraine 
and respiratory diseases. Additionally, subthreshold forms of OCD were associated with specific 
noncommunicable physical diseases. Agoraphobia, specific phobia, and generalized anxiety disorder 
were all associated with whooping cough. The documented comorbidity was associated with increased 
disability and decreased quality of life. 
 
Discussion: The detected comorbidity patterns may contribute to a better understanding of the 
psychobiological pathways of comorbidity. Further, increased burden of individuals affected underlines 
the need for studies evaluating the effect of treatment in comorbid cases.  
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Abstract in German 
Hintergrund: Angststörungen weisen eine hohe Komorbidität mit anderen psychischen Störungen auf. 
Dies hat wichtige Implikationen für die Belastung der Betroffenen, sowie für die Ätiologie und Therapie 
der komorbiden Störungen. Die Datenlage zur Komorbidität mit körperlichen Erkrankungen in der 
Bevölkerung ist jedoch für spezifische Angststörungen eingeschränkt. Die vorliegende Dissertation 
untersucht den Zusammenhang zwischen spezifischen Angststörungen und nichtübertragbaren und 
übertragbaren körperlichen Erkrankungen in der Bevölkerung. Weiter wird die Assoziation der 
Komorbidität mit Lebensqualität und Beeinträchtigung untersucht. 
 
Methode: Analysiert wurden die Daten des Bundesgesundheitssurvey, einer repräsentativen 
Bevölkerungsstichprobe Deutschlands mit 4’181 Probanden im Alter von 18-65 Jahren. Angststörungen 
wurden mit dem DIA-X/M-CIDI Interview erhoben, nichtübertragbare körperliche Erkrankungen mit 
einem ärztlichen Interview, sowie mit einem Fragebogen und übertragbare körperliche Erkrankungen 
mit einem Fragebogen.  
 
Resultate: Sowohl die Zwangsstörung als auch die Spezifische Phobie traten gehäuft mit Migräne und 
Atemwegserkrankungen auf. Auch subklinische Formen der Zwangsstörung waren mit spezifischen, 
nichtübertragbaren körperlichen Erkrankungen assoziiert. Agoraphobie, Spezifische Phobie und 
Generalisierte Angststörung gingen mit erhöhten Prävalenzraten von Keuchhusten einher. Komorbidität 
war mit erhöhter Beeinträchtigung und niedrigerer Lebensqualität assoziiert. 
 
Diskussion: Die Komorbidiätsmuster können zu einem besseren Verständnis der zugrundeliegenden 
Mechanismen beitragen. Die assoziierte Belastung unterstreicht die Bedeutung weiterer Forschung zur 
Wirksamkeit der Therapie bei komorbiden Erkrankungen.  
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We must . . . make efforts to convince decision makers, educators, clinicians, and community 
members that comorbidity is one of the most urgent challenges to the quality of health care in the 
early decades of the twenty first century that must be recognized and dealt with  
without delay.  
—Norman Sartorius, 2013 
Former director of the World Health Organization’s Division of Mental Health 
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Introduction 
Mental disorders are associated with high social and financial burden worldwide (Kessler et al., 
2009; Wittchen et al., 2011). Among the most prevalent mental disorders are anxiety disorders (Jacobi et 
al., 2014) with a 12-month prevalence rate about 14% and 61.5 million individuals affected in Europe 
(Wittchen et al., 2011).  
The majority of individuals with anxiety disorders have at least one additional mental disorder at 
the same time (Jacobi et al., 2004; Kessler, Chiu, Demler, & Walters, 2005). This so-called comorbidity 
(Jacobi, Vossen, & Wittchen, 2009; Wittchen, 1996b) has been impressively documented in clinical 
(Sartorius, Uestuen, Lecrubier, & Wittchen, 1996) and community studies (Kessler et al., 2005) and has 
several important implications.  
In terms of implications for health care costs, studies have shown that comorbidity is associated 
with an increased use of the health system (Souetre et al., 1994). Further, it may have implications for 
the burden of individuals affected as studies have shown that having two conditions at the same time is 
associated with increased impairment in comparison to having one condition (Kessler, DuPont, 
Berglund, & Wittchen, 1999). It may additionally have clinical implications as treatment strategies for 
individuals with several disorders may differ from treatment strategies for individuals affected by a 
single diagnosis (Lieb, Meinlschmidt, & Araya, 2007). In addition, the investigation of patterns of 
comorbidity can have etiological implications as it may contribute to a better understanding of the 
etiological pathways of the comorbid diseases (Lieb, 2006; Merikangas & Swanson, 2010).  
A recent line of evidence suggests that in addition to being comorbid with other mental disorders, 
anxiety disorders are also associated with physical diseases. Clinical and community studies have 
revealed that the group of anxiety disorders is associated with a wide range of noncommunicable 
physical diseases, also known as chronic diseases (Haerter, Conway, & Merikangas, 2003; Roy-Byrne et 
al., 2008). Further, the comorbidity of anxiety disorders and noncommunicable physical diseases seems 
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to affect individuals’ burden, too: Researchers have found that having a noncommunicable physical 
disease in addition to any anxiety disorder is associated with increased disability and poor quality of life 
in comparison to having one condition (Sareen, Cox, Clara, & Asmundson, 2005; Sareen et al., 2006). 
Some studies have additionally suggested that anxiety can complicate the treatment of physical diseases 
and may be associated with worse treatment outcome (Dahlen & Janson, 2002; DiMatteo, Lepper, & 
Croghan, 2000). Therefore, knowledge of the pathways of comorbidity is important as this may inform 
treatment and prevention and hence contribute to the reduction of burden. 
Yet before the pathways behind comorbidity can be unraveled, a careful evaluation of the nature 
of comorbidity is important (Degenhardt, Hall, & Lynskey, 2003). More community studies 
investigating especially the association of specific anxiety disorders and a wide range of physical 
diseases are necessary to gain more consolidated knowledge and to enable the derivation of hypotheses 
concerning etiology of comorbidity. Many studies have employed study designs that limit the validity of 
the findings: On the one hand, studies involving clinical samples may not reflect the natural patterns of 
comorbidity, as comorbidity is associated with treatment seeking behavior (selection bias) (Lieb et al., 
2007). On the other, community studies so far have concentrated mainly on the comorbidity of the whole 
group of anxiety disorders (Sareen et al., 2006). Further, those studies that addressed the comorbidity of 
specific anxiety disorders and noncommunicable physical diseases, focused more on some anxiety 
disorders (e.g., panic disorder; Zaubler & Katon, 1995) than others (e.g., OCD or specific phobia). Also, 
the data of some studies were limited due to methodological issues, such as a lack of standardized 
diagnostic interviews for the assessment of mental disorders (Weisskopf, Chen, Schwarzschild, 
Kawachi, & Ascherio, 2003). 
In addition, the comorbidity of symptoms of anxiety disorders below the diagnostic threshold – 
so called subthreshold forms – and physical diseases should be investigated as research has suggested 
that comorbidity of these subthreshold forms and other mental disorders may be substantial (Adam, 
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Meinlschmidt, Gloster, & Lieb, 2012). Further, comorbidity analyses should also address subtypes of 
specific anxiety disorders, such as those of specific phobia (Sareen, Cox, Clara, & Asmundson, 2005), 
because research has shown that these subtypes may differ in their comorbidity patterns (Becker et al., 
2007). This may have etiological implications for the subtypes. Finally, to further supplement the 
existing knowledge, it is necessary to include communicable physical diseases in the comorbidity 
analyses, as a few recent studies have suggested an association of anxiety disorders and communicable 
diseases (Goodwin, 2011; Leonard & Swedo, 2001; Vogelzangs, Beekman, de Jonge, & Penninx, 2013)!
such as the common cold (Adam, Meinlschmidt, & Lieb, 2012). 
 To summarize, it is important to gather more differentiated knowledge on the comorbidity of 
specific anxiety disorders and noncommunicable and communicable physical diseases in the general 
population. This may provide a basis for the better understanding of their etiological pathways and 
therefore may influence prevention and treatment of the comorbid conditions. 
 The objective of this dissertation is therefore to examine the comorbidity between specific 
anxiety disorders and noncommunicable and communicable physical diseases in the general population 
and the association of comorbidity with measures of burden, namely, quality of life and disability. This 
dissertation comprises three manuscripts (see Appendices A–C). Two manuscripts analyzed the 
association of two specific anxiety disorders and noncommunicable physical diseases: the first 
manuscript addressed the comorbidity of OCD and subthreshold forms with noncommunicable physical 
diseases, the second focused on the association of specific phobia and its subtypes with 
noncommunicable physical diseases. The third manuscript examined the association of different specific 
anxiety disorders and communicable physical diseases in the community.  
The rest of this dissertation is structured as follows: In the Theoretical Background section I 
describe the major theoretical concepts and the research background on which the three manuscripts are 
based. I present the derived specific research questions of the three manuscripts and the overall research 
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questions in the section Research Questions. The Methods section describes the methodology and the 
Results section the major results of the three manuscripts. Finally, in the Discussion I discuss the 
implications, strengths, and limitations. 
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Theoretical Background 
Anxiety Disorders 
Anxiety is a fundamental human feeling that is adaptive in threatening situations. However, if the 
extent and/or the duration of the response of fear are experienced as disproportionately strong, or 
subjectively unfounded, or if the anxiety-producing situation is being consistently avoided, anxiety is 
pathological (Lieb & Wittchen, 2011). Pathological anxiety is the core symptom of anxiety disorders, a 
group of mental disorders that are associated with psychological strain and impairment (Lieb & 
Wittchen, 2011). Anxiety disorders are highly prevalent mental disorders in Europe: Studies have shown 
a 12-month prevalence of about 14% in the community (Jacobi et al., 2014; Wittchen et al., 2011). 
Anxiety disorders are currently classified in the Diagnostic and Statistical Manual of Mental 
Disorders (5th ed.; DSM-5; American Psychiatric Association [APA], 2013) and the International 
Classification of Diseases (10th rev.; ICD-10; World Health Organization [WHO], 1993). However, the 
DIA-X/M-CIDI that was used in the present studies covers DSM-IV (4th ed., DSM-IV; APA, 1994) and 
ICD-10 criteria. The following short description of the anxiety disorders is therefore based on the 
classification of the DSM-IV. Because of limited space, only the main characteristics of specific anxiety 
disorders are presented here. Further, posttraumatic stress disorder is not described, as it was not 
assessed in the study sample used for the analyses.  
Agoraphobia. Agoraphobia is characterized by anxiety about or avoidance of places or situations 
from which escape might be difficult in situations where panic-like symptoms might occur. Such 
situations include public transport, crowds, or stores (APA, 1994). 
 Specific phobia. Individuals with specific phobia experience significant anxiety when they are 
exposed to a specific feared object or situation usually leading to avoiding behavior. Different subtypes 
can be specified: The animal subtype refers to fear related to a specific animal such as a spider or a dog, 
the natural subtype refers to fear related to height, storm, water, the blood-injection subtype refers to fear 
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! ,!
related to seeing blood, injection, or going to the dentist or hospital, the situational subtype refers to fear 
of flying in a plane or of being in a small closed room, in a cellar, tunnel, or elevator and the other 
subtype refers to any other specific fear not matching any other subtype (APA, 1994). 
 Social phobia. Social phobia is characterized by significant anxiety that is experienced in social 
and performance situations such as public eating or speaking. Individuals fear that they will act in an 
embarrassing way or show symptoms that may be humiliating. Individuals with specific phobia either 
avoid the situations or experience distress in the situations (APA, 1994). 
 Panic disorder. Panic disorder is characterized by recurrent unexpected panic attacks, which are 
episodes of intensive fear with a sudden onset. During a panic attack, individuals experience symptoms 
such as shortness of breath, palpitations, discomfort, or fear of losing control. Individuals with panic 
disorder avoid situations in which panic attacks may occur. The DSM-IV differentiates between panic 
disorder with and without agoraphobia (APA, 1994). 
 Generalized anxiety disorder. Individuals with generalized anxiety disorder have worried for at 
least 6 months about a number of events or activities such as work or school performance. Anticipation 
of diseases, accidents, or blows of fate that is associated with several physiological and cognitive 
symptoms such as palpitations or rumination is also characteristic (APA, 1994). 
Obsessive-Compulsive Disorder. Note: In the new DSM-5 classification (APA, 2013), OCD is 
classified in the new chapter on obsessive-compulsive and related disorders. As the study reported here 
was based on DSM-IV criteria, I focus on DSM-IV criteria in the following.  
 OCD is characterized by obsessions and/or compulsions. Obsessions are recurrent and persistent 
thoughts, impulses, or images that cause significant anxiety. Compulsions are repetitive behavior that 
individuals feel driven to perform in response to the obsessions. The aim of the compulsions is to 
prevent or reduce distress or some dreaded situation or event (APA, 1994).  
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Noncommunicable and Communicable Physical Diseases 
The WHO distinguishes between noncommunicable and communicable physical diseases. 
Noncommunicable physical diseases, also known as chronic diseases, are not passed from one person to 
another. Generally, they progress slow and have a long duration (WHO, 2015b). Communicable physical 
diseases, also known as infectious diseases, are caused by a pathogenic microorganism such as a virus, 
bacterium, or a parasite. They can be passed from one person to another (WHO, 2015a).  
Comorbidity 
 The term comorbidity was coined by Feinstein (1970), who introduced the term in the literature 
of physical diseases. From the late 1980s on (Brieger & Marneros, 2000; Krueger & Markon, 2006), the 
term has been used in the psychological literature. This may be attributable to the introduction of the 
DSM-III (3rd ed; APA, 1980) and therefore to the introduction of explicit operational criteria for mental 
disorders. The comorbidity related to epidemiological and clinical research I discuss in this dissertation 
was defined as “the presence of more than one disorder in a person in a defined period of time” 
(Wittchen, 1996b, p.7). Various time intervals such as 6 months, a year, or even lifetime can be used1. 
Mental disorders can occur at the same time as well as at different times during this time interval (Lieb, 
Schreier, & Mueller, 2003). Besides the time interval, the design of the study (cross-section vs. 
longitudinal), the characteristics of the sample (clinical sample vs. general population sample) and 
methods of the assessment (case definition and case identification) are also important to consider for the 
interpretation of comorbidity (Jacobi et al., 2009). Comorbidity can be observed among mental 
disorders, but also among mental disorders and physical diseases. In the following section, I explore the 
association of anxiety disorders and physical diseases. 
Comorbidity of anxiety disorders and noncommunicable physical diseases. Clinical and 
community studies have established associations between the group of anxiety disorders and !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!$!In our data, we used 12 months and lifetime as time intervals, for details see the Methods section. 
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noncommunicable physical diseases. Clinical studies with patients have revealed associations between 
anxiety disorders and thyroid diseases (Lindemann, Zitrin, & Klein, 1984), heart diseases (Haerter et al., 
2003; Kawachi et al., 1994), cardiovascular diseases (Batelaan, ten Have, van Balkom, Tuithof, & de 
Graaf, 2014; Roy-Byrne et al., 2008), hypertension (Haerter et al., 2003), gastrointestinal diseases 
(Haerter et al., 2003), migraine (Haerter et al., 2003; Smitherman, Penzien, & Maizels, 2008), arthritis 
(El-Miedany & Rasheed, 2002; Isik, Koca, Ozturk, & Mermi, 2007), and respiratory diseases (Goodwin 
et al., 2003; Katon, Richardson, Lozano, & McCauley, 2004; Nascimento et al., 2002; Roy-Byrne et al., 
2008; Willgoss & Yohannes, 2013). Community studies have established associations between anxiety 
disorders and thyroid diseases (Patten, Williams, Esposito, & Beck, 2006), respiratory diseases (Scott et 
al., 2007), gastrointestinal diseases (Goodwin, Cowles, Galea, & Jacobi, 2013), arthritis, allergies 
(Sareen et al., 2006), migraine (Merikangas, Angst, & Isler, 1990; Sareen et al., 2006), heart diseases 
(Ormel et al., 2007), and vascular diseases (Goodwin, Davidson, & Keyes, 2009).  
In sum, studies have reported comorbidity of anxiety disorders and noncommunicable physical 
diseases, but the data are limited: The patterns found in clinical samples may not reflect the natural 
patterns of comorbidity because they may be associated with a selection bias (Lieb et al., 2007). 
Additionally, the studies focused mainly on one specific physical disease, whereas for the detection of 
patterns a wide range of physical diseases should be analyzed. Further, much less is known about the 
comorbidity of specific anxiety disorders – as opposed to the whole group – and physical diseases. For 
some specific anxiety disorders, especially OCD and specific phobia, there is a need for further 
community-based studies, as shown in the following. 
Comorbidity of obsessive-compulsive disorder, subthreshold forms, and noncommunicable 
physical diseases. Especially for OCD, the data concerning comorbidity with physical diseases are 
limited. In one study, subjects with OCD reported a decreased physical wellbeing (Stengler-Wenzke, 
Kroll, Riedel-Heller, Matschinger, & Angermeyer, 2007). Another study showed that the presence of 
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any chronic physical condition is associated with an increased prevalence of obsessive-compulsive 
symptoms (OCS; Fullana et al., 2010). It has been established that OCS below the diagnostic threshold 
for full-blown OCD seems to be more prevalent in the general population than the full diagnosis (Angst 
et al., 2004; de Bruijn, Beun, de Graaf, ten Have, & Denys, 2010; Grabe et al., 2001). Subjects with such 
subthreshold forms of OCD showed higher disability and increased health care utilization in comparison 
to subjects without these symptoms (Adam et al., 2012). However, no community study has analyzed the 
association of OCD and its subthreshold forms with physical diseases yet, even though this information 
may be highly relevant for the health care system or may have etiological implications. 
Comorbidity of specific phobia, its subtypes, and noncommunicable physical diseases. 
Community studies have established associations between specific phobia and different 
noncommunicable physical diseases, namely, migraine (Merikangas et al., 1990), respiratory diseases 
(Sareen et al., 2006), ulcer, arthritis (Kessler, Ormel, Demler, & Stang, 2003), vascular diseases 
(Goodwin et al., 2009), and heart diseases (Scott et al., 2013). However, the data are limited as they 
mainly focused on one specific physical disease or they were mainly based on self-report of 
noncommunicable physical diseases (e.g., Kessler et al., 2003). In addition, the comorbidity among 
subtypes of specific phobia and physical diseases has not been evaluated so far, even though the 
subtypes differ in their comorbidity patterns with other mental disorders (Becker et al., 2007; LeBeau et 
al., 2010; Park et al., 2011). It has also been observed that subjects with different subtypes of specific 
phobia differ in their physiological fear response: Blood-injection phobia is associated with vasovagal 
fainting, whereas other phobias are not (LeBeau et al., 2010). The natural subtype of specific phobia was 
further associated with more somatic symptoms than the animal subtype (Ollendick, Raishevich, Davis, 
Sirbu, & Oest, 2010), suggesting that comorbidity among the subtypes and physical diseases might also 
differ and should be analyzed. The gained knowledge might influence research on etiology. 
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Comorbidity of anxiety disorders and communicable physical diseases. The association of 
childhood streptococcal infections and OCD has been widely discussed and may be the most prominent 
example of an association of an anxiety disorder and a communicable physical disease (Leonard & 
Swedo, 2001). Further, community studies have established associations of anxiety disorders and 
communicable physical diseases: Two cross-sectional community studies have revealed that an infection 
in the first year of life (Goodwin, 2011) and having experienced a common cold in the last 12 months is 
associated with anxiety disorders (Adam et al., 2012). Studies targeting biomarkers have shown that 
anxiety disorders are associated with inflammatory markers such as C-reactive protein (Vogelzangs et 
al., 2013) and subjects with higher cytomegalovirus antibodies are more likely to be anxious (Phillips, 
Carroll, Khan, & Moss, 2008). Additionally, in anxious women an impairment of several immune 
functions was found (Arranz, Guayerbas, & de la Fuente, 2007). However, studies addressing the 
comorbidity of specific anxiety disorders and a wide range of communicable physical diseases are still 
lacking. 
Burden of comorbidity. Community studies have revealed that the comorbidity of any mental 
disorder and any physical disease is associated with higher disability (Scott et al., 2009) and more 
impairment (Kessler et al., 2003) compared to only one condition. Regarding the group of anxiety 
disorders, the comorbidity with any noncommunicable physical disease is associated with lower quality 
of life and higher disability (Sareen et al., 2006). However, there is a need for further information 
regarding potential implications of comorbidity for the burden of subjects affected on the level of 
specific anxiety disorders and noncommunicable and communicable physical diseases.  
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Research Questions  
The specific research questions addressed in the three manuscripts arose from the background 
presented above: 
 
Manuscript 1: Physical diseases among persons with obsessive-compulsive symptoms and disorder: A 
general population study (published in Social Psychiatry and Psychiatric Epidemiology) 
• Which noncommunicable physical diseases are associated with OCD and subthreshold forms?  
• Is this comorbidity associated with decreased quality of life? 
Manuscript 2: Associations of specific phobia and its subtypes with physical diseases: An adult 
community study (submitted to PLOS ONE) 
• Which noncommunicable physical diseases are associated with specific phobia and its subtypes?  
• Can the associations established be replicated in a second community-based sample? 
Manuscript 3: Comorbidity of infectious diseases and anxiety disorders in adults and its association with 
quality of life: A community study (published in Frontiers in Public Health) 
• Which communicable physical diseases are associated with specific anxiety disorders?  
• Is this comorbidity associated with increased impairment? 
 
Based on these specific research questions, the overall research questions of the dissertation are the 
following: 
• Over the three manuscripts, what patterns of comorbidity can be detected among specific anxiety 
disorders? 
• What implications for subjects’ burden are associated with the comorbidity? 
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Methods 
Epidemiological Approach 
Epidemiology can be generally defined as “the study of the occurrence and distribution of health-
related events, states, and processes in specified populations, including the study of the determinants 
influencing such processes, and the application of this knowledge to control relevant health problems” 
(Porta, Greenland, Hernan, Dos Santos Silva, & Last, 2014, p.95). Further, epidemiology can be 
separated into two main subdisciplines, descriptive epidemiology and analytical epidemiology. 
Descriptive epidemiology assesses the distribution and course of health-related states or events such as a 
mental disorder in certain populations (Lieb, 2013). Analytical epidemiology concerns factors that can 
contribute to the etiology of mental disorders and how these factors can be implemented in prevention 
(Lieb, 2013). However, the two disciplines can supplement each other, as descriptive analyses may lead 
directly to questions of etiology (Lieb, 2006) as shown later in this dissertation. For both analytical and 
descriptive epidemiology different study designs can be applied that strongly affect the validity of the 
conclusions derived from the studies (Lieb, 2006): clinical trials versus general population surveys, 
experimental versus observational studies, and cross-sectional versus longitudinal studies. Due to the 
limited space in this dissertation, I focus on the characteristics of the design used in the reported 
manuscripts. 
The three manuscripts presented in this dissertation are based on the data of the GHS, which is a 
cross-sectional general population survey. In a cross-sectional survey a defined population is examined 
at one time point regarding a phenomenon of interest (Lieb, 2013; Wittchen & Jacobi, 2011). In a 
general population survey the targeted disorder can be examined independently of a treatment institution 
avoiding a possible selection effect in clinical samples (Lieb, 2013; Wittchen & Jacobi, 2011). Such an 
observational study has the further advantage of being conducted in a naturalistic setting (Lieb, 2013).  
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The German Health Interview and Examination Survey  
 Design and sample. The GHS is the first representative survey in Germany to examine the 
prevalence and comorbidity of physical diseases and mental disorders in the adult population (Jacobi et 
al., 2004; Jacobi et al., 2002). It additionally aimed at providing data about quality of life as well as 
impairment and disability, and estimating the met and unmet needs and service utilization patterns of the 
adult population (Jacobi et al., 2002). The GHS consisted of a core-survey and several linked 
supplementary surveys, including the Mental Health Supplement (GHS-MHS) (Jacobi et al., 2004). The 
GHS-MHS was administered to 4,181 subjects aged 18–65 years. Further information concerning the 
structure of the GHS-MHS can be found elsewhere (Jacobi et al., 2002). 
Measures.  
Anxiety disorders. Anxiety Disorders were assessed with the DIA-X/M-CIDI which is a 
modified version of the WHO’s Composite International Diagnostic Interview, version 1.2 (Wittchen & 
Pfister, 1997) as part of the GHS-MHS. Trained psychologists and physicians conducted the interviews 
in the homes of the respondents. The test-retest reliability and the validity of the diagnoses were good 
(for further details see, Jacobi et al., 2002, and Wittchen, Lachner, Wunderlich & Pfister, 1998). As this 
dissertation focuses on anxiety disorders, the following list presents the anxiety disorders that were 
assessed in the GHS-MHS (for all anxiety disorders 12-month prevalence was assessed, for panic 
disorder lifetime prevalence was additionally assessed). 
• Panic disorder with and without agoraphobia  
• Agoraphobia without the history of panic disorder  
• Specific phobia (animal type, natural type, blood-injection type, situational type, other type) 
• Social phobia  
• Generalized anxiety disorder 
• OCD 
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• Anxiety disorder not otherwise specified 
For our analyses 12-month prevalence of all anxiety disorders was used. 
Subthreshold forms of obsessive-compulsive disorder. OCD symptoms were classified into three 
groups according to the affirmation of the stem questions2 of the DIA-X/M-CIDI and the number of 
DSM-IV criteria fulfilled. The groups were: (a) subthreshold OCD and OCD (subthreshold OCD: one 
stem question, at least one diagnostic criterion, but not all; OCD: full DSM-IV diagnostic criteria), (b) 
OCS (at least one stem question but no DSM-IV diagnostic criteria), and (c) the reference group no OCS 
(no stem question was affirmed). 
Noncommunicable physical diseases. Noncommunicable physical diseases were assessed during 
the core survey using three methods. First, subjects completed a self-report questionnaire, which 
assessed the lifetime prevalence of 44 noncommunicable physical diseases. Second, on the basis of 
subjects’ answers, physicians collected detailed information on lifetime prevalence, 12-month 
prevalence, and point prevalence (4 weeks) of noncommunicable physical diseases. Third, blood 
pressure and anthropometric measurements were conducted and blood and urine samples were collected 
(Jacobi et al., 2002). The final diagnoses were then supplemented and revised based on these laboratory 
analyses. Table 1 shows the groups of noncommunicable physical diseases used for our analyses. These 
analyses are based on 12-month prevalence.  
 
 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!%!In the obsession section of the DIA-X/M-CIDI the stem question refers to a wide range of potential thoughts and 
cognitions. In the compulsion section three stem questions are asked to assess repetitive behaviors. If subjects 
approve at least one of the stem questions they are asked about the mandatory DSM-IV criteria (criteria A: 
diagnostic details of obsessions and compulsions, B: recognition that obsessions or compulsions are excessive or 
unreasonable, and C: evaluation if disorder causes distress or dysfunction). 
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 Communicable physical diseases. Communicable physical diseases were assessed in a paper-
and-pencil questionnaire in the core survey. The subjects had to indicate which of the following 
Table 1 
Noncommunicable Physical Diseases Covered in the German Health Interview and 
Examination Survey (12-Month Prevalence) 
Group of physical diseases Included physical diseases 
Hypertension Hypertension 
Cardiac diseases Heart circulation disturbances, narrowing of the coronary 
vessels, angina pectoris, cardiac infarct, heart weakness, 
heart insufficiency 
Respiratory diseases Asthma, chronic bronchitis 
Gastrointestinal diseases Ulcer, gastritis 
Diabetes Diabetes with or without insulin treatment 
Arthritic conditions Wear-and-tear type, inflammatory diseases of the joints 
Allergies Hay fever, allergic eczema, allergic hives, 
neurodermatitis, food allergy, allergic conjunctivitis 
Migraine headaches Migraine 
Neurological diseases Epilepsy, Parkinson’s disease, multiple sclerosis 
Thyroid diseases Thyroid diseases 
Vascular diseases Stroke, brain circulation disturbance, leg circulation 
disturbances, artery occlusion, varicose veins, vein 
thrombosis 
Note. To facilitate comparisons with prior work, the groups were built according to Sareen et al., 
2006. 
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infectious diseases they had had during their lifetime (lifetime prevalence): diphtheria, whooping cough, 
measles, mumps, rubella, chicken pox, scarlet fever, tuberculosis, dysentery, or typhus. As only lifetime 
prevalence was available, we used this information for our analyses. 
Burden: Disability and quality of life. In this dissertation, disability and quality of life are 
considered as measures of burden. Disability was assessed in the self-report questionnaire of the core 
survey. The subjects were asked whether they were completely or partially unable to carry out daily 
activities (i.e., function in work, school, or family) because of psychological problems or in a second 
question because of physical problems in the 4 weeks before the interview took place.  
 Quality of life was assessed in the core survey with a self-report questionnaire, the German 
version of the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36; Bullinger et al., 
1998). The SF-36 measures health-related quality of life in eight dimensions in the past 30 days 
(physical functioning, social functioning, role limitations due to physical problems, bodily pain, mental 
health, role limitations due to emotional problems, vitality, and general health) and is a well-validated 
instrument (Hopman et al., 2000). Two summary component scales can be derived, the mental and 
physical quality of life (Ware et al., 1998). 
Statistical Analyses 
In all manuscripts, logistic regression analyses were conducted and odds ratios (ORs) were 
calculated. An OR is a measure of association that entails the odd that a certain outcome (e.g. physical 
disease) will occur given a particular exposure (e.g. anxiety disorder) in comparison to the odd of the 
outcome occurring in the absence of that exposure (Hoefler, 2004; Lieb, 2013). For this, no incidence 
rates have to be available. Therefore the OR is an appropriate measure to be used in a cross-sectional 
study (Hoefler, 2004; Lieb, 2013) such as the GHS-MHS. The ORs of the specific associations can be 
found in the respective manuscripts in Appendices A–C.  
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Results  
Noncommunicable Physical Diseases 
Obsessive-compulsive disorder. Subthreshold OCD and OCD were associated with migraine 
and respiratory diseases. Further, OCS were associated with allergies, migraine, and thyroid diseases. 
Regarding disability, we showed that the comorbidity of OCS (combining OCS and subthreshold OCD 
and OCD) and any noncommunicable physical disease was associated with the highest number of days 
of disability due to physical or psychological problems during the past 30 days compared to subjects 
with only OCS, only physical disease or neither of them. We further checked whether the combined 
effect of both OCS and physical disease on disability is larger than the sum of the individual effects 
(called biological interaction, see Rothman, 2002). We did not find such an interaction suggesting 
independence of OCS and physical diseases as risk factors for disability (see Appendix A). 
Specific phobia. Specific phobia was associated with cardiac diseases, gastrointestinal diseases, 
migraine, respiratory diseases, arthritic conditions, and thyroid diseases. Among subtypes, different 
patterns were detected. The situational subtype was associated with the most physical diseases. The 
results are summarized in Table 2. 
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Table 2 
Associations Between Obsessive-Compulsive Disorder and Its Subthreshold Forms, and Specific Phobia 
and Its Subtypes, with Noncommunicable Physical Diseases from Manuscripts 1 and 2 
Anxiety disorder  
(12-month prevalence) 
Associated noncommunicable disease 
(12-month prevalence) 
Subthreshold OCD and OCD Migraine, respiratory diseases  
OCS Allergies, migraine, thyroid diseases 
Specific phobia Migraine, respiratory diseases, cardiac diseases, gastrointestinal 
diseases, arthritic conditions, thyroid diseases 
Specific phobia subtype: 
  Animal  Gastrointestinal diseases, respiratory diseases, allergies 
  Natural Migraine 
  Blood-Injection Respiratory diseases 
  Situational Gastrointestinal diseases, arthritic conditions, migraine, thyroid 
diseases 
  Other Thyroid diseases 
Note. OCD = obsessive-compulsive disorder; OCS = obsessive-compulsive symptoms.  
We replicated the associations of specific phobia with respiratory diseases and migraine in a second 
population-based sample from Lausanne, Switzerland (Preisig et al., 2009). Among subtypes, the animal 
and natural subtypes were associated with respiratory diseases and migraine (see Appendix B). 
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Communicable Physical Diseases 
Regarding communicable diseases, we established associations of three anxiety disorders 
(agoraphobia, specific phobia, and generalized anxiety disorder) and whooping cough as can be seen in 
Table 3. Panic disorder was associated only with diphtheria, whereas agoraphobia was associated with 
four communicable diseases: whooping cough, mumps, scarlet fever, and tuberculosis. We further 
established that having one or more anxiety disorders was associated with an increased number of 
infectious diseases compared to having no anxiety disorder. However, analyses revealed that having 
more than one anxiety disorder did not further increase the number of infectious diseases relative to 
having one anxiety disorder. Concerning quality of life, the comorbidity of any anxiety disorder with a 
communicable physical disease was associated with lower both mental and physical quality of life 
compared to only one or neither condition (see Appendix C). 
Table 3 
Associations Between Anxiety Disorders and Communicable Physical Diseases in the German Health 
Interview and Examination Survey – Mental Health Supplement from Manuscript 3 
Anxiety disorders  
(12-month prevalence) 
Associated communicable diseases  
(lifetime prevalence) 
Panic disorder 
Agoraphobia without panic disorder 
Diphtheria  
Whooping cough, mumps, scarlet fever, tuberculosis  
Specific phobia 
Generalized anxiety disorder 
Whooping cough  
Whooping cough  
Note. No associations were found between social phobia, OCD, and anxiety disorder not otherwise specified with 
communicable physical diseases.  
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Patterns 
Over the three manuscripts, the following patterns were detected (only including the group 
subthreshold OCD/OCD [in the following called OCD in combination with patterns] and specific phobia 
not separated by the subtypes): First, OCD and specific phobia were both associated with migraine and 
respiratory diseases. Second, three anxiety disorders, namely, agoraphobia, specific phobia, and 
generalized anxiety disorder were associated with whooping cough. 
Burden 
Over the two manuscripts assessing measures for subjects burden (manuscripts 1 and 3), 
comorbidity was associated with increased burden in terms of a loss of quality of life and increased 
disability, as seen in Table 4. 
Table 4 
Associations of Comorbidity With Measures of Burden From Manuscripts 1 and 3 
 
 
 
 
 
 
Note. OCS includes OCS, subthreshold OCD, and OCD. 
  
Assessed comorbidity  Associated measure of burden 
OCS and any noncommunicable physical 
disease 
Increased disability 
Any anxiety disorder and any communicable 
physical disease 
Decreased mental and physical 
quality of life 
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Discussion 
This dissertation complements the existing research on the comorbidity of specific anxiety 
disorders and physical diseases in that it analyzed the comorbidity of specific phobia and OCD with a 
wide range of noncommunicable physical diseases in the community based on a consolidated 
methodological approach. Further, the manuscripts demonstrate that even subthreshold forms of OCD 
show increased prevalence rates with specific noncommunicable physical diseases and that the subtypes 
of specific phobia differ in their comorbidity patterns. Additionally, the analyses demonstrate that 
specific anxiety disorders are associated not only with noncommunicable physical diseases, but also with 
specific communicable physical diseases. Last, the findings indicate that comorbidity is associated with 
increased burden. 
General Implications of the Manuscripts 
Subthreshold forms. The comorbidity analyses on subthreshold forms of OCD highlight that even 
symptoms of an anxiety disorder presently not captured by the DSM-IV diagnostic criteria are associated 
with increased prevalence of specific noncommunicable physical diseases. This shows that not only a 
full-blown diagnosis but also subthreshold symptoms are clinically meaningful and therefore should be 
recognized and treated in clinical care. Because some noncommunicable physical diseases were only 
associated with OCS and not subthreshold OCD or OCD or vice versa, it may be that different 
etiological factors are related to OCS, subthreshold OCD and OCD. Future studies evaluating the 
etiology of comorbidity should also include subthreshold forms of OCD to examine this hypothesis.  
Subtypes. Different patterns of comorbidity with noncommunicable physical diseases among the 
subtypes of specific phobia were established. This matches with previous research showing different 
patterns of comorbidity with mental disorders among subtypes (Becker et al., 2007). The different 
patterns might point towards different etiological mechanisms such as different biological processes that 
may play a role in the different subtypes. 
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Communicable diseases. The analyses revealed that specific anxiety disorders are comorbid not 
only with noncommunicable physical diseases, but also with specific communicable physical diseases. 
Therefore research should target immunological processes that may play a role in the emergence of 
comorbidity. 
Because the single associations of specific anxiety disorders and specific physical diseases have 
been discussed in the respective manuscripts (Appendices A–C), in the following discussion I focus on 
the implications of the patterns over the three manuscripts. 
Major Implications of the Patterns  
As our data encompassed a broad range of physical diseases, it was possible to detect patterns of 
comorbidity with a sound methodology that included physician-diagnosed noncommunicable physical 
diseases. The analyses therefore constitute a major contribution to the existing research. Two patterns 
among noncommunicable physical diseases, namely, the association of specific phobia and OCD with 
both migraine and respiratory diseases were revealed. It is noticeable that these two patterns match with 
previous research establishing associations of anxiety disorders with migraine (Breslau, Davis, & 
Andreski, 1991; Ratcliffe, Enns, Jacobi, Belik, & Sareen, 2009) and respiratory diseases (Goodwin, 
Fergusson, & Horwood, 2004; Hasler et al., 2005) in studies focusing on the particular physical disease. 
Our analyses therefore underline the importance of these patterns and further indicate that the 
associations with migraine and respiratory diseases seem not to be specific to a particular anxiety 
disorder. This may lead to crucial hypotheses regarding etiology of comorbidity that will be discussed in 
the following section. 
We also examined the comorbidity of specific anxiety disorders and communicable physical 
diseases, which provides a further complement to the comorbidity research. From this, we established a 
third pattern, namely, associations of whooping cough with agoraphobia, specific phobia, and 
generalized anxiety disorder that may also have etiological implications. 
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! %)!
Etiological considerations of the patterns. Several models have been proposed for the etiology 
of the comorbidity that can be basically characterized by the following scenarios (excluding explanations 
due to methodological shortcomings, Lieb, 2015; Wittchen, 1996a): Two models assume that anxiety 
disorders and physical diseases are causally linked. Either an anxiety disorder causes a temporally 
secondary physical disease or the physical disease causes a temporally secondary anxiety disorder (Lieb, 
2015; Sareen et al., 2006). The third model assumes that anxiety disorders and physical diseases share 
common genetic, environmental, or personality factors that contribute to the co-occurrence (Lieb, 2015; 
Sareen et al., 2006). To further clarify the interplay of the comorbid conditions, once an association has 
been established, the next step is to evaluate the temporal sequence (Lieb, 2015). Addressing the 
predictive association of two disorders makes it possible to deduce if one disorder might be a risk factor 
for another disorder (Kraemer et al., 1997). However, being a risk factor for another disorder does not 
imply causality. In addition to a risk association, other criteria need to be examined to determine whether 
an association of two disorders is causal (see also Rothman & Greenland, 2005). 
As some temporal sequences are more probable than others for the comorbidity patterns, I 
discuss these in the next section to provide hypotheses for future studies trying to unravel the 
psychobiological underpinnings of the comorbidity.  
Migraine. Reviewing studies that have evaluated the temporal sequence of any anxiety disorder 
and migraine in retrospective assessments in cross-sectional or even in longitudinal studies suggests that 
the group of anxiety disorders generally precedes migraine (Breslau et al., 1991; Merikangas et al., 1990; 
Merikangas, Merikangas, & Angst, 1993; Waldie & Poulton, 2002). However, much less is known 
concerning the temporal sequence of specific anxiety disorders and migraine. A population survey 
revealed a median age at onset of migraine of 24 years for men and 25 years for women (Stewart, Wood, 
Reed, Roy, & Lipton, 2008). Studies on the age at onset of specific phobia and OCD have revealed that 
specific phobia emerges during childhood or youth (Lieb et al., 2003) whereas OCD emerges during 
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early adulthood (Reinecker, 2011). This suggests that specific phobia might precede migraine, whereas 
OCD might emerge during the same time period as migraine. Regarding data about the temporal 
sequence of specific phobia and OCD with migraine, one study established that specific phobia was 
predictive of migraine, whereas for OCD this association was not established (Swartz, Pratt, Armenian, 
Lee, & Eaton, 2000) matching with the age at onset findings reported above. Based on our analyses with 
a broad range of physical diseases and complemented by the existing research, I suggest that specific 
phobia might be a risk factor (according to Kraemer et al., 1997) for migraine. 
However, the same cannot be assumed for OCD, because OCD seems not to precede migraine 
but to emerge during the same time period as migraine, as shown by the age at onset reports. On the 
basis of these temporal considerations and the fact that the associations seem not to be specific to a 
particular anxiety disorder, I propose that the group of anxiety disorders and migraine might share 
certain common etiological factors that may increase the risk of both disorders. Therefore in my opinion 
the model including shared factors seems more plausible than a causality model for a specific anxiety 
disorder. This is supported by some psychobiological considerations: As both OCD (Micallef & Blin, 
2001) and specific phobia (Zohar & Westenberg, 2000) are associated with serotonin abnormalities and 
migraine has been associated with serotonin abnormalities (Hamel, 2007), too, this might be a common 
psychobiological factor. Further, it has been reported that some anxiety disorders are associated with a 
corticotropin-releasing hormone (CRH) dysfunction (Risbrough & Stein, 2006). CRH is a peptide that is 
thought to be a key signal within the hypothalamic-pituitary-adrenal (HPA) axis in the stress response of 
an organism and leads to the release of cortisol (Sauro & Becker, 2009). Sauro and Becker (2009)!
further proposed that stress can trigger migraine through an increased activation of the CRH release. It 
may therefore be that individuals with specific phobia or OCD show an altered CRH release which is 
also associated with migraine. !
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Respiratory diseases. The patterns also show that the associations with respiratory diseases seem 
to be unspecific to a particular anxiety disorder, too. Regarding the temporal sequence, studies have 
shown that a bidirectional association, namely, anxiety disorders generally preceding respiratory 
diseases and respiratory diseases preceding anxiety disorders, is possible (Hasler et al., 2005; Katon et 
al., 2004; Roy-Byrne et al., 2008). Psychobiological explanations such as hyperventilation associated 
with anxiety or anxiogenic properties of asthma medications have been discussed for both directions 
(Roy-Byrne et al., 2008).  
Regarding especially OCD and specific phobia, the high-risk periods for the first manifestations 
of OCD (early adulthood) and specific phobia (childhood or youth) seem to overlap with those of 
respiratory diseases (childhood and adolescence; see Katon et al., 2004). Promising research has 
suggested that shared etiological factors (either environmental or genetic) of some anxiety disorders and 
respiratory diseases may account for the comorbidity (Goodwin et al., 2004; Roy-Byrne et al., 2008). 
For such factors, a genetic vulnerability to both asthma and anxiety disorders has been discussed. In 
addition, a longitudinal study revealed that childhood adversities are associated with both asthma and 
anxiety disorders (Goodwin et al., 2004). Therefore I suggest that the model including shared etiological 
factors of both respiratory diseases and anxiety disorders is the most plausible yet. 
 Whooping cough. We established associations of agoraphobia, specific phobia, and generalized 
anxiety disorders with whooping cough. Regarding their temporal sequence, I would postulate the 
following: The age at onset of whooping cough is thought to be mainly in early childhood, namely, the 
first years of life (Wendelboe, Van Rie, Salmaso, & Englund, 2005), whereas specific phobia emerges 
for the first time during childhood or youth (Lieb et al., 2003). Agoraphobia and generalized anxiety 
disorder have their age at onset later in adolescence or in adulthood (Lieb et al., 2003). Additionally, a 
cross-sectional study reported that infections in the first year of life (assessed retrospectively) are 
associated with an increased risk of anxiety disorders in childhood (Goodwin, 2011). Taking all this 
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information into account, I suggest that whooping cough might precede the three anxiety disorders and 
therefore could be a risk factor for some anxiety disorders, namely, specific phobia, agoraphobia, and 
generalized anxiety disorder.  
With the combined results of manuscripts 2 and 3, we showed that specific phobia was associated 
not only with whooping cough but also with respiratory diseases. Other studies have stated that early life 
infections may increase the probability of asthma in childhood (Busse, Lemanske, & Gern, 2010; 
Mackenzie, Anderton, & Schwarze, 2014). Taking into account this information and the already 
described association of infections in the first year of life (assessed retrospectively) and an increased risk 
of anxiety disorders in childhood (Goodwin, 2011), I postulate that whooping cough as an infectious 
disease might be a common risk factor of both asthma and specific phobia. Whooping cough may act as 
an early life stressor that might be associated with an increased expression of pro-inflammatory 
cytokines (Hou, Tang, & Baldwin, 2012; Leonard & Myint, 2009; Tonon et al., 2002). It has been shown 
that these cytokines can change the metabolism of serotonin and the function of the HPA axis via the 
release of CRH and cortisol (Hou et al., 2012). As specific phobia is associated with an altered serotonin 
function (Zohar & Westenberg, 2000), this matches with the postulated pathway. This example shows 
that combining information from the associations of specific anxiety disorders and both 
noncommunicable and communicable physical diseases might contribute to new hypotheses regarding 
the etiology of comorbidity.  
Considerations of the patterns for the new DSM-5 classification. As previously stated in the 
Theoretical Background section, in the new DSM-5, OCD is now classified in the group of obsessive-
compulsive and related disorders. This is due to emerging evidence that OCD has several features such 
as an obsessive preoccupation or repetitive behaviors in common with body dysmorphic disorder, 
trichotillomania, hoarding disorder, and excoriation disorder (APA, 2013) and research showing 
similarities in courses of illness and comorbidity patterns with other mental disorders (Phillips et al., 
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! &-!
2010). Mental disorders are classified by a descriptive, atheoretical approach, independent of possible 
etiological considerations (Wittchen, 2011). From this descriptive point of view, besides comorbidity 
with mental disorders, comorbidity with physical diseases may provide further information on what 
physical disorders occur more frequently among individuals with a specific mental disorder. Two 
disorders classified in the same group of disorders might therefore show similar comorbidity patterns 
among mental disorders (Phillips et al., 2010) but also among physical diseases. The patterns in our 
manuscripts suggest that OCD and specific phobia show associations with the same noncommunicable 
physical diseases, namely, migraine and respiratory diseases. The data also show that specific phobia 
was in addition associated with other noncommunicable physical diseases with which OCD was not 
associated. Further, OCD was not associated with any communicable physical disease, whereas other 
anxiety disorders were associated with specific communicable diseases. Therefore comparing 
comorbidity patterns of OCD and anxiety disorders in our manuscripts, it is not evident whether they 
differ in their comorbidity patterns, which one might expect given the new classification. Future 
manuscripts could examine comorbidity of other obsessive-compulsive spectrum disorders with physical 
diseases and evaluate if the comorbidity patterns of OCD are more similar to those of other obsessive- 
compulsive spectrum disorders or to those of anxiety disorders. For this, more comparable data on the 
comorbidity of the other obsessive-compulsive spectrum disorders and a broad range of physical 
diseases are needed. These considerations show that our analyses of comorbidity with physical disease 
might also provide a basis for future considerations of classification. 
Major Implications of the Burden of Comorbidity 
 The comorbidity of OCD even under the diagnostic threshold and a noncommunicable physical 
disease was associated with increased disability. In manuscript 1, we suggest that the increased disability 
associated with comorbidity of OCD and a physical disease is an additive effect as no indication of 
interaction was found. To reduce disability in an additive model as suggested by our data, it is important 
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to treat both conditions to reduce their joint disability (Scott et al., 2009). Therefore the manuscripts 
presented underline the need for the recognition and treatment of both anxiety disorders and physical 
diseases and may thereby also provide crucial knowledge for health care policy. The importance of 
recognition of comorbid conditions is supported by studies showing that anxiety disorders may be 
associated with noncompliance (DiMatteo et al., 2000) or worse treatment outcomes of the physical 
disease (Dahlen & Janson, 2002). For treatment, studies indicate that cognitive-behavioral therapy is 
effective in reducing anxiety symptoms in subjects with specific noncommunicable physical diseases 
(Kariuki-Nyuthe & Stein, 2015). However, more randomized controlled trials are needed to evaluate 
therapy in individuals with specific anxiety disorders and comorbid physical diseases. This might also 
guide treatment choices in individuals with both conditions.  
 Further, the comorbidity of an anxiety disorder and a communicable physical disease was 
associated with decreased quality of life. This shows that communicable diseases that are generally more 
time limited than noncommunicable physical diseases may additionally play an important role in the 
quality of life of individuals affected. Moreover, as infectious diseases such as whooping cough may be 
a risk factor for specific anxiety disorders, this additionally supports the need for preventive strategies of 
infectious diseases, such as vaccination. 
Strengths of the Manuscripts 
• Representative sample: A clear strength of the manuscripts presented here is the use of a 
representative community sample of subjects aged 18–65 years in Germany. Therefore the 
analyses are not limited by sampling biases found in treatment-seeking samples. 
• Case identification: Anxiety disorders were assessed with a valid and reliable clinical interview 
(DIA-X/M-CIDI). As noncommunicable physical diseases were assessed by physicians and 
supplemented by laboratory measures, the results are less limited by recall biases than 
community surveys using self-report measures.  
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• Case definition: As the DIA-X/M-CIDI is based on DSM-IV criteria, this constitutes an 
improvement to some earlier studies that did not use diagnostic criteria of specific anxiety 
disorders. 
• Different anxiety disorders: As many different anxiety disorders were assessed in the GHS-MHS, 
analyses including different specific anxiety disorders were possible. 
• A broad range of physical diseases: A broad range of physical diseases was assessed, which 
enabled the detection of comorbidity patterns among many different physical diseases.  
• Noncommunicable and communicable physical diseases: The integration of communicable 
physical diseases in the comorbidity analyses provides a new perspective on mental-physical 
comorbidity and therefore for possible etiological implications. 
• Assessment of quality of life: The measure used for quality of life (SF-36) is a reliable and valid 
measure.  
• Replication: In manuscript 2, we partially replicated our findings of the associations of specific 
phobia and noncommunicable physical diseases. More studies are needed to replicate the 
findings of the other manuscripts. 
Limitations of the Manuscripts 
• Generalizability: As the targeted population was subjects living in Germany aged 18-65 years 
with sufficient German language skills, the results cannot be generalized to subjects aged 
younger than 18 or older than 65 years. Further, no conclusions can be drawn for subjects who 
are nonregistered in Germany, subjects living in community institutions such as a hospital, or 
have insufficient language skills.  
• Sample size: In some anxiety disorders the sample size was rather small. When combined with 
physical diseases the sample size became even smaller. Therefore it is possible that some 
associations could not be established even though they might exist. 
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• Causality: Due to the cross-sectional design used, no causal inferences can be drawn. No models 
concerning the etiology of comorbidity can therefore be excluded. 
• Communicable physical diseases: As the prevalence rates of communicable physical diseases 
were based on self-reports, it may be that some diseases were misunderstood (e.g. whooping 
cough could be a generic cough or a symptom of asthma). Even though there are studies showing 
that the validity of self-report of some communicable physical diseases is high (Macintyre & 
Pritchard, 1989) future studies should assess infectious diseases with a medical interview or by 
laboratory blood tests. Further, we had lifetime information only for the communicable diseases, 
whereas for anxiety disorders, 12-month prevalence was available. Future studies should use the 
same time frame to increase comparability. 
Outlook 
There is a need for longitudinal studies of the comorbidity of specific anxiety disorders and a 
wide range of noncommunicable and communicable physical diseases in the community that address the 
temporal sequence of the diseases. These studies should also include neurobiological (e.g., CRH) and 
immunological parameters to further evaluate possible shared mechanisms relevant for comorbidity. 
Further, future studies could also evaluate possible mediators or moderators of the association of anxiety 
disorders and physical diseases that might modify the associations (e.g., physical activity). Additionally, 
more research is needed to establish the associations of subthreshold forms of specific anxiety disorders 
and physical diseases in the community and to test whether different etiological mechanisms are 
involved in specific phobia subtypes. Future studies should also evaluate the influence of comorbidity on 
treatment outcome of comorbid conditions, especially for specific anxiety disorders such as OCD and 
examine the effect of treatment of an anxiety disorder on the physical disease and vice versa.  
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Overall Conclusions 
This dissertation shows that specific anxiety disorders are highly comorbid with specific 
noncommunicable and communicable physical diseases in the general population and that even 
subthreshold forms may show substantial comorbidity. The manuscripts reported in this dissertation 
established patterns of associations of both specific phobia and OCD with migraine and respiratory 
diseases. Further, agoraphobia, specific phobia, and generalized anxiety disorders were all associated 
with whooping cough. These patterns – supplemented by the already existing research on other specific 
anxiety disorders – suggest that the migraine-anxiety association and the respiratory diseases-anxiety 
associations are not specific to a particular anxiety disorder. Considerations of the temporal sequence 
and psychobiological processes further suggest that the comorbidity of both specific anxiety disorders 
and the two noncommunicable physical diseases might be better explained by shared etiological factors 
than by a causality model. The associations of anxiety disorders and communicable physical diseases 
highlight that immunological processes should also be considered as possible mechanisms in the 
etiology of comorbidity. Further, comorbidity was associated with increased burden even in 
subthreshold forms of specific anxiety disorders or with communicable physical diseases. This might 
have unique implications for treatment and prevention. 
In sum, this dissertation contributes to a better understanding of the comorbidity of anxiety 
disorders and physical diseases in the community as it may influence future research evaluating the 
etiology of comorbidity and provide a first step to optimize treatment strategies for comorbid conditions 
that aim to reduce burden of individuals affected. 
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Scientific knowledge is knowledge, not fact—a gallery of pictures painted by scientists to portray 
in some simplified, comprehensive way the (seemingly) infinite complexity of nature. The 
pictures are put up and taken down, cleaned, replaced, and destroyed. Any account of scientific 
knowledge is therefore . . . an account of unfinished business.  
       
—Holden, 1980 
 
 
  
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! &)!
References 
Adam, Y., Meinlschmidt, G., Gloster, A. T., & Lieb, R. (2012). Obsessive-compulsive disorder in the 
community: 12-month prevalence, comorbidity and impairment. Social Psychiatry and 
Psychiatric Epidemiology, 47, 339–349. doi: 10.1007/s00127-010-0337-5 21287144 
Adam, Y., Meinlschmidt, G., & Lieb, R. (2012). Associations between mental disorders and the 
common cold in adults: A population-based cross-sectional study. Journal of Psychosomatic 
Research, 74, 69–73. doi: 10.1016/j.jpsychores.2012.08.013 
American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders  
(3rd ed.). Washington, DC: Author. 
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders  
(4th ed.). Washington, DC: Author. 
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders  
(5th ed.). Washington, DC: Author. 
Angst, J., Gamma, A., Endrass, J., Goodwin, R.D., Ajdacic, V., Eich, D., & Roessler, W. (2004). 
Obsessive-compulsive severity spectrum in the community: Prevalence, comorbidity, and course. 
European Archives of Psychiatry and Clinical Neuroscience, 254(3), 156–164.  
doi: 10.1007/s00406-004-0459-4 
Arranz, L., Guayerbas, N., & de la Fuente, M. (2007). Impairment of several immune functions in 
anxious women. Journal of Psychosomatic Research, 62, 1–8.  
doi: 10.1016/j.jpsychores.2006.07.030 
Batelaan, N. M., ten Have, M., van Balkom, A. J. L. M., Tuithof, M., & de Graaf, R. (2014). Anxiety 
disorders and onset of cardiovascular disease: The differential impact of panic, phobias and 
worry. Journal of Anxiety Disorders, 28, 252–258. doi: 10.1016/j.janxdis.2013.12.003 
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! &*!
Becker, E. S., Rinck, M., Tuerke, V., Kause, P., Goodwin, R.D., Neumer, S., & Margraf, J. (2007). 
Epidemiology of specific phobia subtypes: Findings from the Dresden Mental Health Study. 
European Psychiatry, 22, 69–74. doi: 10.1016/j.eurpsy.2006.09.006 
Breslau, N., Davis, G. C., & Andreski, P. (1991). Migraine, psychiatric disorders, and suicide attempts: 
An epidemiologic study of young adults. Psychiatry Research, 37, 11–23. doi: 10.1016/0165-
1781(91)90102-U 
Brieger, P., & Marneros, A. (2000). Komorbiditaet bei psychiatrischen Krankheiten – Einige 
theoretische Überlegungen. Der Nervenarzt, 71, 525–534.  
Bullinger, M., Alonso, J., Apolone, G., Leplege, A., Sullivan, M., Wood-Dauphinee, S., . . . Bech, P. 
(1998). Translating health status questionnaires and evaluating their quality: The IQOLA project 
approach. Journal of Clinical Epidemiology, 51, 913–923. doi: 10.1016/S0895-4356(98)00082-1 
Busse, W. W., Lemanske, R. F., & Gern, J. E. (2010). Role of viral respiratory infections in asthma and 
asthma exacerbations. The Lancet, 376, 826–834. doi: 10.1016/S0140-6736(10)61380-3 
Dahlen, I., & Janson, C. (2002). Anxiety and depression are related to the outcome of emergency 
treatment in patients with obstructive pulmonary disease. CHEST Journal, 122, 1633–1637.  
doi: 10.1378/chest.122.5.1633 
De Bruijn, C., Beun, S., de Graaf, R., ten Have, M., & Denys, D. (2010). Subthreshold symptoms and 
obsessive compulsive disorder: Evaluating the diagnostic threshold. Psychological Medicine, 40, 
989–997. doi: 10.1017/S0033291709991012 
Degenhardt, L., Hall, W., & Lynskey, M. (2003). What is comorbidity and why does it occur? In M. 
Teesson & H. Proudfoot (Eds.), Comorbid mental disorders and substance use disorders: 
Epidemiology, prevention and treatment (pp. 10–20). Sydney, Australia: National Drug and 
Alcohol Research Centre, University of New South Wales. 
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! &+!
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance 
with medical treatment: Meta-analysis of the effects of anxiety and depression on patient 
adherence. Archives of Internal Medicine, 160, 2101–2107. doi: 10.1001/archinte.160.14.2101 
El-Miedany, Y. M., & Rasheed, A. H. E. (2002). Is anxiety a more common disorder than depression in 
rheumatoid arthritis? Joint Bone Spine, 69, 300–306. doi: 10.1016/S1297-319X(02)00368-8 
Feinstein, A. R. (1970). The pre-therapeutic classification of co-morbidity in chronic disease. Journal of 
Chronic Disease, 23, 455–468. doi: 10.1016/0021-9681(70)90054-8 
Fullana, M. A., Vilagut, G., Rojas-Farreras, S., Mataix-Cols, D., de Graaf, R., Demyttenaere, K., . . . 
Matschinger, H. (2010). Obsessive-compulsive symptom dimensions in the general population: 
Results from an epidemiological study in six European countries. Journal of Affective Disorders, 
124, 291–299. doi: 10.1016/j.jad.2009.11.020 
Goodwin, R. D. (2011). Association between infection early in life and mental disorders among youth in 
the community: A cross-sectional study. BMC Public Health, 11, 878. doi: 10.1186/1471-2458-
11-878 
Goodwin, R. D., Cowles, R. A., Galea, S., & Jacobi, F. (2013). Gastritis and mental disorders. Journal of 
Psychiatric Research, 47, 128–132. doi: 10.1016/j.jpsychires.2012.09.016 
Goodwin, R. D., Davidson, K. W., & Keyes, K. (2009). Mental disorders and cardiovascular disease 
among adults in the United States. Journal of Psychiatric Research, 43, 239–246.  
doi: 10.1016/j.jpsychires.2008.05.006 
Goodwin, R. D., Fergusson, D. M., & Horwood, L. (2004). Asthma and depressive and anxiety disorders 
among young persons in the community. Psychological Medicine, 34, 1465–1474.  
doi: 10.1017/S0033291704002739  
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! &,!
Goodwin, R. D., Olfson, M., Shea, S., Lantigua, R. A., Carrasquilo, O., Gameroff, M. J., & Weissman, 
M. M. (2003). Asthma and mental disorders in primary care. General Hospital Psychiatry, 25, 
479–483. doi: 10.1016/S0163-8343(03)00071-9 
Grabe, H. J., Meyer, C., Hapke, U., Rumpf, H. J., Freyberger, H. J., Dilling, H., & John, U. (2001). 
Lifetime-comorbidity of obsessive-compulsive disorder and subclinical obsessive-compulsive 
disorder in Northern Germany. European Archives of Psychiatry and Clinical Neuroscience, 251, 
130–135. doi: 10.1007/s004060170047 
Haerter, M. C., Conway, K. P., & Merikangas, K. R. (2003). Associations between anxiety disorders and 
physical illness. European Archives of Psychiatry and Clinical Neuroscience, 253, 313–320.  
doi: 10.1007/s00406-003-0449-y 
Hamel, E. (2007). Serotonin and migraine: biology and clinical implications. Cephalalgia, 27, 1293–
1300. doi: 10.1111/j.1468-2982.2007.01476.x 
Hasler, G., Gergen, P. J., Kleinbaum, D. G., Ajdacic, V., Gamma, A., Eich, D., . . . Angst, J. (2005). 
Asthma and panic in young adults: A 20-year prospective community study. American Journal of 
Respiratory and Critical Care Medicine, 171, 1224–1230. doi: 10.1164/rccm.200412-1669OC  
Hoefler, M. (2004). Statistik in der Epidemiologie psychischer Stoerungen. Berlin, Germany: Springer. 
Hopman, W. M., Towheed, T., Anastassiades, T., Tenenhouse, A., Poliquin, S., Berger, C., . . . Adachi, 
J. D. (2000). Canadian normative data for the SF-36 health survey. Canadian Medical 
Association Journal, 163, 265–271.  
Hou, R., Tang, Z., & Baldwin, D. S. (2012). Potential neuroimmunological targets in the treatment of 
anxiety disorders. Modern Trends in Pharmacopsychiatry, 29, 67–84. doi: 10.1159/000351965  
Isik, A., Koca, S. S., Ozturk, A., & Mermi, O. (2007). Anxiety and depression in patients with 
rheumatoid arthritis. Clinical Rheumatology, 26, 872–878. doi: 10.1007/s10067-006-0407-y 
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! '-!
Jacobi, F., Hoefler, M., Siegert, J., Mack, S., Gerschler, A., Scholl, L., . . . Seiffert, I. (2014). Twelve-
month prevalence, comorbidity and correlates of mental disorders in Germany: The Mental 
Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-
MH). International Journal of Methods in Psychiatric Research, 23, 304–319.  
doi: 10.1002/mpr.1439 
Jacobi, F., Vossen, A., & Wittchen, H.-U. (2009). Komorbiditaetsstrukturen bei 
Angststoerungen‚Haeufigkeit und moegliche Implikationen. In J. Margraf & S. Schneider (Eds.), 
Lehrbuch der Verhaltenstherapie (pp. 433–447). Berlin, Germany: Springer. 
Jacobi, F., Wittchen, H.-U., Holting, C., Hoefler, M., Pfister, H., Mueller, N., & Lieb, R. (2004). 
Prevalence, co-morbidity and correlates of mental disorders in the general population: Results 
from the German Health Interview and Examination Survey (GHS). Psychological Medicine, 34, 
597–611. doi: 10.1017/S0033291703001399 
Jacobi, F., Wittchen, H.-U., Holting, C., Sommer, S., Lieb, R., Hofler, M., & Pfister, H. (2002). 
Estimating the prevalence of mental and somatic disorders in the community: Aims and methods 
of the German National Health Interview and Examination Survey. International Journal of 
Methods in Psychiatric Research, 11, 1–18.  
Kariuki-Nyuthe, C., & Stein, D. J. (2015). Anxiety and Related Disorders and Physical Illness. In N. 
Sartorius, R. I. G. Holt, & M. Maj (Eds.), Comorbidity of Mental and Physical Disorders (pp. 
81–87). Basel: Karger. 
Katon, W. J., Richardson, L., Lozano, P., & McCauley, E. (2004). The relationship of asthma and 
anxiety disorders. Psychosomatic Medicine, 66, 349–355.  
Kawachi, I., Colditz, G. A., Ascherio, A., Rimm, E. B., Giovannucci, E., Stampfer, M. J., & Willett, W. 
C. (1994). Prospective study of phobic anxiety and risk of coronary heart disease in men. 
Circulation, 89, 1992–1997. doi: 10.1161/01.CIR.89.5.1992 
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! '$!
Kessler, R. C., Aguilar-Gaxiola, S., Alonso, J., Chatterji, S., Lee, S., Ormel, J., . . . Wang, P. S. (2009). 
The global burden of mental disorders: An update from the WHO World Mental Health (WMH) 
surveys. Epidemiologia e Psichiatria Sociale, 18, 23–33. doi: 10.1017/S1121189X00001421 
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity 
of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of 
General Psychiatry, 62, 617–627. doi: 10.1001/archpsyc.62.6.617 
Kessler, R. C., DuPont, R. L., Berglund, P., & Wittchen, H.-U. (1999). Impairment in pure and comorbid 
generalized anxiety disorder and major depression at 12 months in two national surveys. 
American Journal of Psychiatry, 156, 1915–1923.  
Kessler, R. C., Ormel, J., Demler, O., & Stang, P. E. (2003). Comorbid mental disorders account for the 
role impairment of commonly occurring chronic physical disorders: Results from the National 
Comorbidity Survey. Journal of Occupational and Environmental Medicine, 45, 1257–1266.  
doi: 10.1097/01.jom.0000100000.70011.bb 
Kraemer, H. C., Kazdin, A. E., Offord, D. R., Kessler, R. C., Jensen, P. S., & Kupfer, D. J. (1997). 
Coming to terms with the terms of risk. Archives of General Psychiatry, 54, 337–343.  
Krueger, R. F., & Markon, K. E. (2006). Reinterpreting comorbidity: A model-based approach to 
understanding and classifying psychopathology. Annual Review of Clinical Psychology, 2, 111–
133. doi: 10.1146/annurev.clinpsy.2.022305.095213 
LeBeau, R. T., Glenn, D., Liao, B., Wittchen, H.-U., Beesdo-Baum, K., Ollendick, T., & Craske, M. G. 
(2010). Specific phobia: A review of DSM-IV specific phobia and preliminary recommendations 
for DSM-V. Depression and Anxiety, 27, 148–167. doi: 10.1002/da.20655 
Leonard, B. E., & Myint, A. (2009). The psychoneuroimmunology of depression. Human 
Psychopharmacology: Clinical and Experimental, 24(3), 165–175. doi: 10.1002/hup.1011 
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! '%!
Leonard, H. L., & Swedo, S. E. (2001). Paediatric autoimmune neuropsychiatric disorders associated 
with streptococcal infection (PANDAS). The International Journal of 
Neuropsychopharmacology, 4, 191–198. doi: 10.1017/S1461145701002371 
Lieb, R. (2006). Klinische Psychologie I: Klassifikation, Epidemiologie und Praevention psychischer 
Stoerungen. In K. Pawlik (Ed.), Handbuch Psychologie Wissenschaft - Anwendung - Berufsfelder 
(pp. 613–638). Heidelberg, Germany: Springer. 
Lieb, R. (2013). Epidemiologie psychischer Stoerungen. Psych up2date, 7, 317–328. doi: 10.1055/s-
0033-1349425 
Lieb, R. (2015). Epidemiological perspectives on comorbidity between substance use disorders and other 
mental disorders. In G. Dom & F. Moggi (Eds.), Co-occurring Addictive and Psychiatric 
Disorders (pp. 3–12). Berlin, Germany: Springer. 
Lieb, R., Meinlschmidt, G., & Araya, R. (2007). Epidemiology of the association between somatoform 
disorders and anxiety and depressive disorders: An update. Psychosomatic Medicine, 69, 860–
863. doi: 10.1097/PSY.0b013e31815b0103 
Lieb, R., Schreier, A., & Mueller, N. (2003). Epidemiologie von Angststoerungen. Psychotherapie, 8, 
86–102.  
Lieb, R., & Wittchen, H.-U. (2011). Angststoerungen: Klassifikation und Diagnostik. In M. Perrez & U. 
Baumann (Eds.), Lehrbuch Klinische Psychologie - Psychotherapie (pp. 894–904). Bern, 
Switzerland: Hans Huber. 
Lindemann, C. G., Zitrin, C. M., & Klein, D. F. (1984). Thyroid dysfunction in phobic patients. 
Psychosomatics, 25, 603–606. doi: 10.1016/S0033-3182(84)72995-1 
Macintyre, S., & Pritchard, C. (1989). Comparisons between the self-assessed and observer-assessed 
presence and severity of colds. Social Science & Medicine, 29, 1243–1248. doi: 10.1016/0277-
9536(89)90063-4 
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! '&!
Mackenzie, K. J., Anderton, S. M., & Schwarze, J. (2014). Viral respiratory tract infections and asthma 
in early life: Cause and effect? Clinical & Experimental Allergy, 44, 9–19.  
doi: 10.1111/cea.12139 
Merikangas, K. R., Angst, J., & Isler, H. (1990). Migraine and psychopathology: Results of the Zurich 
cohort study of young adults. Archives of General Psychiatry, 47, 849–853.  
doi: 10.1001/archpsyc.1990.01810210057008 
Merikangas, K. R., Merikangas, J. R., & Angst, J. (1993). Headache syndromes and psychiatric 
disorders: Association and familial transmission. Journal of Psychiatric Research, 27, 197–210. 
doi: 10.1016/0022-3956(93)90008-P 
Merikangas, K. R., & Swanson, S. A. (2010). Comorbidity in anxiety disorders. In M. B. Stein & T. 
Steckler (Eds.), Behavioral neurobiology of anxiety and its treatment (pp. 37–59). Berlin, 
Germany: Springer. 
Micallef, J., & Blin, O. (2001). Neurobiology and clinical pharmacology of obsessive-compulsive 
disorder. Clinical Neuropharmacology, 24, 191–207.  
Nascimento, I., Nardi, A. E., Valenca, A. M., Lopes, F. L., Mezzasalma, M. A., Nascentes, R., & Zin, 
W. A. (2002). Psychiatric disorders in asthmatic outpatients. Psychiatry Research, 110, 73–80. 
doi: 10.1016/S0165-1781(02)00029-X 
Ollendick, T. H., Raishevich, N., Davis, T. E., Sirbu, C., & Oest, L.-G. (2010). Specific phobia in youth: 
Phenomenology and psychological characteristics. Behavior Therapy, 41, 133–141.  
doi: 10.1016/j.beth.2009.02.002 
Ormel, J., Von Korff, M., Burger, H., Scott, K., Demyttenaere, K., Huang, Y., . . . Levinson, D. (2007). 
Mental disorders among persons with heart disease - Results from World Mental Health surveys. 
General Hospital Psychiatry, 29, 325–334. doi: 10.1016/j.genhosppsych.2007.03.009 
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! ''!
Park, S., Cho, M. J., Chang, S. M., Jeon, H. J., Cho, S.-J., Kim, B.-S., . . . Hong, J. P. (2011). 
Prevalence, correlates, and comorbidities of adult ADHD symptoms in Korea: Results of the 
Korean epidemiologic catchment area study. Psychiatry Research, 186, 378–383.  
doi: 10.1016/j.psychres.2010.07.047 
Patten, S. B., Williams, J. V. A., Esposito, E., & Beck, C. A. (2006). Self-reported thyroid disease and 
mental disorder prevalence in the general population. General Hospital Psychiatry, 28, 503–508. 
doi: 10.1016/j.genhosppsych.2006.09.001 
Phillips, A. C., Carroll, D., Khan, N., & Moss, P. (2008). Cytomegalovirus is associated with depression 
and anxiety in older adults. Brain, Behavior, and Immunity, 22, 52–55.  
doi: 10.1016/j.bbi.2007.06.012 
Phillips, K. A., Stein, D. J., Rauch, S. L., Hollander, E., Fallon, B. A., Barsky, A., . . . Saxena, S. (2010). 
Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? 
Depression and Anxiety, 27, 528–555. doi: 10.1002/da.20705 
Porta, M. S., Greenland, S., Hernan, M., Dos Santos Silva, I., & Last, J. M. (2014). A dictionary of 
epidemiology. New York, NY: Oxford University Press. 
Preisig, M., Waeber, G., Vollenweider, P., Bovet, P., Rothen, S., Vandeleur, C., . . . Muglia, P. (2009). 
The PsyCoLaus study: methodology and characteristics of the sample of a population-based 
survey on psychiatric disorders and their association with genetic and cardiovascular risk factors. 
BioMedCentral Psychiatry, 9. doi: 10.1186/1471-244X-9-9 
Ratcliffe, G. E., Enns, M. W., Jacobi, F., Belik, S.-L., & Sareen, J. (2009). The relationship between 
migraine and mental disorders in a population-based sample. General Hospital Psychiatry, 31, 
14–19. doi: 10.1016/j.genhosppsych.2008.09.006 
Reinecker, H. S. (2011). Zwangsstoerungen. In H.-U. Wittchen & J. Hoyer (Eds.), Klinische Psychologie 
& Psychotherapie (pp. 1005–1019). Berlin, Germany: Springer. 
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! '(!
Risbrough, V. B., & Stein, M. B. (2006). Role of corticotropin releasing factor in anxiety disorders: A 
translational research perspective. Hormones and Behavior, 50, 550–561.  
doi: 10.1016/j.yhbeh.2006.06.019 
Rothman, K. J. (2002). Epidemiology: An introduction. New York, NY: Oxford University Press. 
Rothman, K. J., & Greenland, S. (2005). Causation and causal inference in epidemiology. American 
Journal of Public Health, 95, 144–150. doi: 10.2105/AJPH.2004.059204 
Roy-Byrne, P. P., Davidson, K. W., Kessler, R. C., Asmundson, G. J., Goodwin, R. D., Kubzansky, L.,  
. . . Stein, M. B. (2008). Anxiety disorders and comorbid medical illness. General Hospital 
Psychiatry, 30, 208–225. doi: 10.1016/j.genhosppsych.2007.12.006 
Sareen, J., Cox, B.J., Clara, I., & Asmundson, G.J.G. (2005). The relationship between anxiety disorders 
and physical disorders in the U.S. National Comorbidity Survey. Depression and Anxiety, 21, 
193–202. 
Sareen, J., Jacobi, F., Cox, B. J., Belik, S. L., Clara, I., & Stein, M. B. (2006). Disability and poor quality 
of life associated with comorbid anxiety disorders and physical conditions. Archives of Internal 
Medicine, 166, 2109–2116. doi: 10.1001/archinte.166.19.2109. 
Sartorius, N., Uestuen, T. B., Lecrubier, Y., & Wittchen, H.-U. (1996). Depression comorbid with 
anxiety: Results from the WHO study on psychological disorders in primary health care. The 
British Journal of Psychiatry, 168(Suppl.30), 38–43.  
Sauro, K. M., & Becker, W. J. (2009). The stress and migraine interaction. Headache: The Journal of 
Head and Face Pain, 49, 1378–1386. doi: 10.1111/j.1526-4610.2009.01486 
Scott, K. M., Bruffaerts, R., Tsang, A., Ormel, J., Alonso, J., Angermeyer, M. C., . . . Von Korff, M. 
(2007). Depression-anxiety relationships with chronic physical conditions: Results from the 
World Mental Health Surveys. Journal of Affective Disorders, 103, 113–120.  
doi: 10.1016/j.jad.2007.01.015 
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! ')!
Scott, K. M., de Jonge, P., Alonso, J., Viana, M. C., Liu, Z., O'Neill, S., . . . Stein, D. J. (2013). 
Associations between DSM-IV mental disorders and subsequent heart disease onset: Beyond 
depression. International Journal of Cardiology, 168, 5293–5299.  
doi: 10.1016/j.ijcard.2013.08.012 
Scott, K. M., Von Korff, M., Alonso, J., Angermeyer, M. C., Bromet, E., Fayyad, J., . . . Gureje, O. 
(2009). Mental-physical co-morbidity and its relationship with disability: Results from the World 
Mental Health Surveys. Psychological Medicine, 39, 33–43. doi: 10.1017/S0033291708003188 
Smitherman, T. A., Penzien, D. B., & Maizels, M. (2008). Anxiety disorders and migraine intractability 
and progression. Current Pain and Headache Reports, 12, 224–229. doi: 10.1007/s11916-008-
0039-9 
Souetre, E., Lozet, H., Cimarosti, I., Martin, P., Chignon, J., Ades, J., . . . Darcourt, G. (1994). Cost of 
anxiety disorders: Impact of comorbidity. Journal of Psychosomatic Research, 38, 151–160.  
Stengler-Wenzke, K., Kroll, M., Riedel-Heller, S., Matschinger, H., & Angermeyer, M. C. (2007). 
Quality of life in obsessive-compulsive disorder: The different impact of obsessions and 
compulsions. Psychopathology, 40, 282–289. doi: 10.1159/000104744 
Stewart, W. F., Wood, C., Reed, M. L., Roy, J., & Lipton, R. B. (2008). Cumulative lifetime migraine 
incidence in women and men. Cephalalgia, 28, 1170–1178.  
Swartz, K. L., Pratt, L. A., Armenian, H. K., Lee, L. C., & Eaton, W. W. (2000). Mental disorders and 
the incidence of migraine headaches in a community sample: Results from the Baltimore 
Epidemiologic Catchment area follow-up study. Archives of General Psychiatry, 57, 945–950. 
doi: 10.1001/archpsyc.57.10.945 
Tonon, S., Goriely, S., Aksoy, E., Pradier, O., Del Giudice, G., Trannoy, E., . . . De Wit, D. (2002). 
Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell 
activation in whole blood: Impaired responses in human newborns. European Journal of 
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! '*!
Immunology, 32, 3118–3125. doi: 10.1002/1521-4141(200211)32:11<3118::AID-
IMMU3118>3.0.CO;2-B 
Vogelzangs, N., Beekman, A. T. F., de Jonge, P., & Penninx, B. W. J. H. (2013). Anxiety disorders and 
inflammation in a large adult cohort. Translational Psychiatry, 3, e249. doi: 10.1038/tp.2013.27 
Ware, J.E., Krosinski, M., Gandek, B., Aaronson, N.K., Apolone, G., Bech, P., . . . Sullivan, M. (1998). 
The factor structure of the SF-36 health survey in 10 countries: results from the IQOLA project. 
Journal of Clinical Epidemiology, 51, 59–65. doi:10.1016/S0895-4356(98)00107-3 
Waldie, K. E., & Poulton, R. (2002). Physical and psychological correlates of primary headache in 
young adulthood: A 26 year longitudinal study. Journal of Neurology, Neurosurgery & 
Psychiatry, 72, 86–92. doi: 10.1136/jnnp.72.1.86  
Weisskopf, M. G., Chen, H., Schwarzschild, M. A., Kawachi, I., & Ascherio, A. (2003). Prospective 
study of phobic anxiety and risk of Parkinson's disease. Movement Disorders, 18, 646–651.  
doi: 10.1002/mds.10425 
Wendelboe, A. M., Van Rie, A., Salmaso, S., & Englund, J. A. (2005). Duration of immunity against 
pertussis after natural infection or vaccination. The Pediatric Infectious Disease Journal, 24,  
58–61.  
Willgoss, T. G., & Yohannes, A. M. (2013). Anxiety disorders in patients with COPD: A systematic 
review. Respiratory Care, 58, 858–866. doi: 10.4187/respcare.01862 
Wittchen, H.-U. (1996a). Critical issues in the evaluation of comorbidity of psychiatric disorders. The 
British Journal of Psychiatry, 168, 9–16.  
Wittchen, H.-U. (1996b). What is comorbidity–Fact or artefact? The British Journal of Psychiatry. 
Supplement, 168(Suppl.30), 7–8.  
Wittchen, H.-U. (2011). Diagnostische Klassifikation psychischer Stoerungen. In H.-U. Wittchen & J. 
Hoyer (Eds.), Klinische Psychologie & Psychotherapie (pp. 28–54). Berlin, Germany: Springer. 
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! '+!
Wittchen, H.-U., & Jacobi, F. (2011). Epidemiologische Beitraege zur Klinischen Psychologie. In H.-U. 
Wittchen & J. Hoyer (Eds.),  Klinische Psychologie & Psychotherapie (pp. 57–90). Berlin, 
Germany: Springer. 
Wittchen, H.-U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Joensson, B., . . . Faravelli, C. 
(2011). The size and burden of mental disorders and other disorders of the brain in Europe 2010. 
European Neuropsychopharmacology, 21, 655–679. doi: 10.1016/j.euroneuro.2011.07.018 
Wittchen, H.-U., Lachner, G., Wunderlich, U., Pfister, H. (1998). Test-retest reliability of the 
computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-
CIDI). Social Psychiatry and Psychiatric Epidemiology, 33, 568–578. 
Wittchen, H.-U., & Pfister, H. (1997). DIA-X-Interviews: Manual für das Screening-Verfahren und 
Interview; Interviewheft Laengsschnittuntersuchung (DIA-X-Lifetime); Ergaenzungsheft (DIA-X-
Lifetime): Interviewheft Querschnittsuntersuchung (DIA-X-12 Monate); Ergaenzungsheft (DIA-
X-12 Monate); PC-Programm zur Durchfuehrung des Interviews (Laengs- und 
Querschnittuntersuchung); Auswertungsprogramm. Frankfurt, Germany: Swets & Zetilinger. 
World Health Organization. (1993). Tenth Revision of the International Classification of Diseases (10th 
rev.). Geneva, Switzerland: Author. 
World Health Organization. (2015a). Health topics: Infectious diseases. Retrieved from 
http://www.who.int/topics/infectious_diseases/en/ 
World Health Organization. (2015b). Noncommunicable diseases (Fact sheet). Retrieved from 
http://www.who.int/mediacentre/factsheets/fs355/en/ 
Zaubler, T. S., & Katon, W. (1995). Panic disorder and medical comorbidity: A review of the medical 
and psychiatric literature. Bulletin of the Menninger Clinic, 60(2 Suppl A), A12–38.  
ANXIETY DISORDERS AND PHYSICAL DISEASES 
  !
! ',!
Zohar, J., & Westenberg, H. G. M. (2000). Anxiety disorders: a review of tricyclic antidepressants and 
selective serotonin reuptake inhibitors. Acta Psychiatrica Scandinavica, 101, 39–49.  
doi: doi/10.1111/j.1600-0447.2000.tb10947 
  !
!
 
      Appendix A 
 
Physical diseases among persons with obsessive compulsive symptoms and disorder:  
a general population study 
 
 
 
Cornelia Witthauer, Andrew T. Gloster, Andrea H. Meyer, Roselind Lieb 
 
published in Social Psychiatry and Psychiatric Epidemiology 
 
 
 
 
 
 
 
 
 
 
  
  !
!
Soc Psychiatry Psychiatr Epidemiol (2014) 49:2013–2022 
DOI 10.1007/s00127-014-0895-z !
OR IGINAL  PAPER  !!!
Physical diseases among persons with obsessive compulsive 
symptoms and disorder: a general population study !
Cornelia  Witthauer •  Andrew  T. Gloster  • 
Andrea  Hans Meyer •  Roselind Lieb !!!!!!
Received: 27 March 2013 / Accepted: 25 May 2014 / Published online: 8 June 2014 
© The Author(s) 2014. This article is published with open access at Springerlink.com !!
Abstract 
Purpose    This study aimed at evaluating the comorbidity 
between DSM-IV obsessive compulsive disorder (OCD) and 
subthreshold forms and physical diseases in the general 
population as well as disability associated with comorbidity. 
Methods   We used data from the  1998 German Mental 
Health Survey, a representative survey of the German popu- 
lation. Mental disorders and physical diseases of 4181 subjects 
(aged 18–65) were cross-sectionally assessed. Mental disor- 
ders were diagnosed using the M-CIDI/DIA-X interview. 
Physical diseases were assessed through a self-report ques- 
tionnaire and a standardized medical interview. We created 
three  groups of  obsessive–compulsive symptoms:  (1)  no 
obsessive compulsive symptoms (n = 3,571); (2) obsessive 
compulsive symptoms (OCS, n = 371; endorsement of OCS 
(either obsession or compulsion) without fulfilling any core 
DSM-IV criteria); (3) subthreshold OCD/OCD (n = 239; 
fulfilling either some or all of the core DSM-IV criteria). 
Results In comparison to subjects without OCS, subjects 
with subthreshold OCD/OCD showed higher prevalence rates 
of migraine headaches (OR 1.7; 95 % CI 1.1–2.5) and respi- 
ratory diseases (OR 1.7; 95 % CI 1.03–2.7); subjects with OCS 
showed higher prevalence rates of allergies (OR 1.6; 95 % CI 
1.1–2.8), migraine headaches (OR 1.9; 95 % CI 1.4–2.7) and 
thyroid disorders (OR 1.4; 95 % CI 1.01–2.0). Subjects with 
both OCS and physical disease reported the highest number of 
days of disability due to physical or psychological problems 
during the past 30 days compared to subjects with only OCS, 
only physical disease or neither of them. 
 
C. Witthauer   A. T. Gloster   A. H. Meyer   R. Lieb 
Department of Psychology, Division of Clinical Psychology and 
Epidemiology, University of Basel, Missionsstrasse 62a, 
4055 Basel, Switzerland 
e-mail: roselind.lieb@unibas.ch 
Conclusions   OCD and subthreshold forms are associated 
with higher comorbidity rates with specific physical diseases 
and higher disability than subjects without OCS. Possible 
etiological pathways should be evaluated in future studies 
and clinicians in primary care should be aware of these 
associations. !
Keywords  OCD   Subthreshold types   Physical disease  
Epidemiology   Obsessive compulsive symptoms  
Disability !
Abbreviations 
OCD Obsessive compulsive disorder 
OCS Obsessive compulsive symptoms 
GHS-MHS German health interview and examination 
survey and its mental health supplement 
DIA-X/M-CIDI The Munich composite international 
diagnostic interview 
DSM-IV Diagnostic and statistical manual of 
mental disorders, Fourth Edition 
ICD-10 International classification of diseases, 
Tenth Edition 
CI Confidence interval 
OR Odds ratio 
IRR Incidence risk ratio 
RERI Relative excess risk due to interaction 
AP The attributable proportion due to 
interaction 
S Synergy index !!
Introduction !
There  is  increasing  evidence  that  mental  disorders  fre- 
quently   co-occur  with  physical  diseases  [1–4].  Such
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comorbidity  between  mental  and  physical  diseases  has 
been found in patients diagnosed with schizophrenia, 
bipolar disorder, schizoaffective disorder and major 
depressive disorder [5]. Among these patients, nutritional 
and metabolic diseases, cardiovascular diseases, viral dis- 
eases, respiratory tract diseases, musculoskeletal diseases, 
pregnancy complications and stomatognathic diseases were 
found to be more prevalent than in the general population 
[1, 6, 7]. Due to their higher risk of cardiovascular diseases, 
patients with affective disorders are even known to be at 
high risk for premature death [4, 8]. 
There is evidence from patients and community-based 
studies that physical health problems are also associated 
with anxiety disorders [2, 3, 9, 10]. Significant associations 
between anxiety disorders and cardiac disorders, hyper- 
tension, gastrointestinal problems, genitourinary disorders 
and migraine have been found in patients recruited from 
treatment and community sources [2]. Additionally, 
increased rates of arthritis, asthma and ulcers were detected 
in patients with anxiety disorders [10]. Likewise, popula- 
tion surveys showed that depressive and anxiety disorders 
without comorbidity were associated in equal degree with 
physical conditions [3]. In addition, analyses revealed that 
the presence of an anxiety disorder was significantly 
associated with thyroid disease, respiratory disease, gas- 
trointestinal disease, arthritis, migraine headaches and 
allergic conditions in the general population [9]. Even 
community samples across different countries showed that 
anxiety disorders occurred at higher rates in persons with 
heart  diseases compared  to  those  without  heart  disease 
[11]. Moreover, community analyses revealed that specific 
anxiety disorders are also significantly associated with 
medically explained pain symptoms, unexplained pain 
symptoms and pain disorder [12]. 
This mental-physical comorbidity has negative conse- 
quences for subjects’ disability in daily life. Subjects with 
comorbid physical and anxiety disorders are more likely to 
be severely disabled than subjects with either condition 
alone  [9,  13,  14].  This  may  suggest  that  it  should  be 
ensured that subjects with mental-physical comorbidity 
receive enough clinical care in order to recognize and treat 
both disorders. 
Additionally, cross-sectional analyses of the association 
of specific physical diseases with certain mental disorders 
can lead to hypotheses concerning etiological mechanisms 
at least in subgroups of affected subjects. For example, 
asthma has been found to be associated with panic disorder 
in many cross-sectional community-based studies [15]. 
These findings stimulated longitudinal studies to evaluate 
the role of smoking as an etiological factor in asthma and 
panic disorder [15]. This illustrates how hypotheses of 
certain etiological factors can be derived from cross-sec- 
tional associations of mental-physical comorbidity. 
Based on the fact that several studies showed associa- 
tions between many mental disorders and specific physical 
diseases, we will report for the first time the association of 
specific physical diseases and OCD and disability related to 
this comorbidity. This is important because epidemiologi- 
cal studies showed that across anxiety disorders obsessive 
compulsive disorder (OCD) was found to be the disorder 
with the highest estimate of the number of life years lost 
due to the disease in men and second highest in women 
behind panic disorder [16]. Increased health care utilization 
among individuals with OCD [17] and decreased physical 
wellbeing (referring to physical health, sleep and pain) in 
patients  with  OCD  [18]  were  found.  Additionally,  one 
study revealed that the presence of any chronic physical 
condition increases the prevalence of obsessive–compul- 
sive symptoms [19]. Furthermore, it is known that sub- 
threshold types of OCD that do not fulfill all DSM-IV 
diagnostic criteria are more prevalent in the general pop- 
ulation compared to OCD [20–22]. Adam et al. [17] could 
show that subjects with such ‘‘subthreshold’’ OCD (i.e. 
fulfilling some but not all core DSM-IV criteria) and 
obsessive compulsive symptoms (i.e. endorsement of stem 
questions without fulfilling any core DSM-IV criteria) 
report higher disability and increased health care utilization 
in the community than subjects without these symptoms. 
To our knowledge no community study about the 
physical health problems of individuals with OCD and 
subthreshold forms has been published, even though sub- 
threshold forms of OCD are known to be associated with 
comparable disability as full diagnostic OCD. As shown 
above, these analyses are relevant for implications of the 
health care system and to generate etiological hypotheses 
of OCD. 
In this report we, therefore, evaluate the association 
between physical diseases and individuals with OCD and 
subthreshold forms in the general population and the dis- 
ability associated with comorbidity. For this purpose we 
use  representative  community  data  from  the  German 
Health Interview and Examination Survey and its Mental 
Health Supplement. !!
Method !
Design and sample !
We used Data from the German Health Interview and 
Examination Survey and its Mental Health Supplement 
(GHS-MHS) conducted in 1997. The GHS was the first 
nationwide cross-sectional study for medical and social 
assessments in Germany and was commissioned by the 
German Ministry of Science, Research and Education and 
the Robert Koch Institute and authorized by the relevant 
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institutional review board and ethics committee. The aim 
of the core study was the assessment of sociodemographic 
characteristics, physical diseases, impairments and health- 
care utilization in a representative community sample of 
7,124 subjects aged 18–79 (overall response rate 61.5 %). 
It was a stratified, randomized sample from 113 commu- 
nities throughout Germany with 130 sampling units (sam- 
pling steps: (1) selection of communities, (2) selection of 
sampling units, (3) selection of inhabitants) [23, 24]. To 
handle   the   stratified  sampling  design  the   data   were 
weighted and confidence intervals were calculated by the 
Huber-White sandwich method to account for the weight- 
ing scheme as well as the stratified sampling design [24]. 
For the assessment of mental disorders in the GHS- 
MHS, a two-stage design was used: The first stage entailed 
the administration of a 12-item screening questionnaire for 
mental disorders at the end of the medical examination of 
the core survey (CID-S) [25]. The second stage involved 
the administration of a structured psychopathological 
interview, the Munich Composite International Diagnostic 
Interview  (DIA-X/M-CIDI), to  all  core  survey  subjects 
who had screened positive for a mental disorder and to a 
random sample of 50 % who screened negative [25]. This 
subsample  of  the  GHS  built  the  sample  of  the  Mental 
Health  Supplement  and  included  4,181  subjects  aged 
18–65 years. The conditional response rate (i.e., subjects 
who completed the M-CIDI interview) was 87.6 %. All 
subjects gave their informed consent. Further description of 
aims, design and methods as well as sociodemographic 
characteristics  of  the  whole  GHS-MHS  sample  can  be 
found elsewhere [23]. !
Assessment of OCD !
For the diagnostic assessments, a modified version of the 
fully structured interview DIA-X/M-CIDI was used [26]. 
The questions covered DSM-IV and ICD-10 criteria. The 
DIA-X interview enables the assessments of symptoms, 
syndromes and onset, duration and severity. The interview 
was conducted by trained psychologists and physicians 
[27]. The test–retest reliability for OCD was found to be 
excellent  (k = 0.81)  with  an  average  time  interval  of 
38 days between interviews in a sample of 60 subjects in 
the community. The validity of the DIA-X/M-CIDI OCD 
diagnoses compared to diagnoses from independent treat- 
ing physicians in a sample of 68 randomly chosen patients 
was also excellent (k = 0.91). The sensitivity was 100 %, 
while the specificity was 98.4 % [17, 28]. 
The  DIA-X/M-CIDI  module  for  OCD  includes  two 
parts: one for the assessment of obsessions and one for the 
assessment of compulsions. In each part, stem questions are 
asked at the beginning. In the obsession section the stem 
question refers to a wide range of potential thoughts and 
cognitions  presented  in  the  form  of  a  symptom  list: 
‘‘During the last 12 month, have you been bothered by 
having certain unpleasant thoughts or images like recurrent 
arbitrary thoughts, such as the idea that your hands are 
dirty or have germs on them?’’ (yes or no). In the com- 
pulsion section three stem questions are asked to assess 
repetitive behaviors (‘‘doing something like washing hands 
over and over again (yes or no) or ‘‘checking several times 
whether the door is locked’’ (yes or no) or mental acts 
(‘‘counting something like tiles in a floor’’ (yes or no)). If 
the subject approves one of these stem questions, they are 
subsequently asked for the  mandatory DSM-IV criteria. 
The DSM-IV mandatory criteria include criteria A for the 
diagnostic details of obsessions and compulsions, criteria B 
for the recognition that the obsessions or compulsions are 
excessive or unreasonable and C for the evaluation if the 
disorder causes distress or dysfunction. Diagnostic criteria 
refer to the past 12 months. 
To  facilitate  comparisons  with  prior  work  [17],  this 
paper splits the sample into the following three mutually 
exclusive groups: !
1. Subthreshold   OCD/OCD   (either   (a)   subthreshold 
OCD: the subject affirmed at least one of the stem 
questions for obsessive or compulsive symptoms and 
fulfilled at least one of the DSM-IV diagnostic criteria 
A,  B  or  C,  but  not  the  full  DSM-IV  criteria,  or 
(b) OCD: the subject met full DSM-IV criteria A, B 
and C for OCD) 
2. OCS (the subject affirmed at least one of the stem 
questions for obsessive or compulsive symptoms, but 
did not fulfill any of the DSM-IV criteria A, B or C) 
3. No OCS (the subject did not affirm any of the stem 
questions for obsessions or compulsions) !
Due to the small group size of full diagnostic OCD (see 
Table 1)  and  the  small  cell  sizes  when  combined  with 
physical diseases, we merged the groups OCD and sub- 
threshold OCD (group 1) in contrast to Adam et al. [17]. !
Assessment of physical conditions !
In the GHS, physical conditions were assessed by a self- 
report questionnaire and a standardized computer-assisted 
medical interview by a general practice physician. 
Based on the information on physical diseases in the 
self-report questionnaire, the physicians conducted infor- 
mation about lifetime prevalences, 12-month prevalences 
and point prevalences (4 weeks) of 44 physical diseases 
[23]. 
Additionally anthropometric and blood pressure mea- 
surements were conducted as well as blood and urine 
samples.  Based  on  these  laboratory  analyses  diagnoses 
were then supplemented and revised [23]. The following 
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Table 1  12-month prevalences of no OCS, OCS and subthreshold 
OCD/OCD and physical diseases in the total sample (n = 4,181) 
No. (%) 
no OCS 3,571 (86.5) 
OCS    371 (8.3) 
Subthreshold OCD/OCD    239 (5.2) 
Subthreshold OCD 201 (4.5) 
OCD   38 (0.7) 
Hypertension    581 (13.1) 
OCS was higher in the separated, divorced or widowed 
subjects group. More details can be seen elsewhere [17]. !
Statistical analyses !
Comorbidity between OCS and physical diseases !
We used logistic regression [odds ratio (OR) with 95 % 
confidence intervals (CI)] to examine associations between 
the groups OCS and subthreshold OCD/OCD and physical 
Cardiac diseases (heart circulation disturbances, 
Narrowing of the coronary vessels, angina, pectoris, 
cardiac infarct, heart weakness, heart, insufficiency) 
100 (2.2) diseases. We considered a p value <0.05  as statistically 
significant. For the logistic regression analyses we used the 
Respiratory diseases (asthma, chronic bronchitis)              284 (7.0) 
Gastrointestinal diseases (ulcer, gastritis)                            268 (6.3) 
Diabetes (with or without insulin treatment)                       115 (2.7) 
STATA software package, version 11.0 [29]. !
Disability 
Arthritic conditions (wear and tear type, inflammatory 
diseases of the joints) 
Allergies (hay fever, allergic eczema, allergic hives, 
neurodermatitis, food allergy, allergic conjunctivitis) 
1,107 (25.9) !
747 (18.1) 
!
To analyze the association between OCS and physical 
disease on the risk of physical or psychological disability 
we  used  the  two  factors  OCS  (combining  both  OCS 
Migraine headaches 491 (10.3) groups) and physical disease (which includes any of the 
Neurological diseases (epilepsy, parkinson disease, 
multiple sclerosis) 
27 (0.5) physical diseases), both having two levels (yes or no). To 
determine whether comorbidity of OCS and physical dis- 
Thyroid diseases 445 (10.0) ease were associated with an increased likelihood of past 
Vascular diseases (stroke, brain circulation 
disturbance, leg circulation disturbances, artery 
  occlusion, varicose veins, vein thrombosis) 
536 (12.4) 30-day disability due to physical or psychological prob- 
lems, we considered the zero inflated negative binomial 
model and the Hurdle model as these models account for 
OCS obsessive–compulsive symptoms, OCD obsessive–compulsive 
disorder, No. unweighted number of subjects, % weighted percentage !!
analyses are based on the physicians’ diagnoses during the 
medical interview. We, therefore, grouped the disorders 
into eleven groups of disorders (see Table 1). !
Assessment of disability !
Disability was assessed by asking the subjects whether he 
or she was completely or partially unable to carry out daily 
activities (i.e., function in work, in school or in family), 
because of psychological problems in the 4 weeks before 
the interview took place (yes or no) and whether he or she 
was completely or partially unable to carry out daily 
activities  (function  in  work,  in  school  or  in  family), 
because of physical problems in the 4 weeks before the 
interview took place (yes or no). !
Sociodemographic correlates !
For the present sample, earlier analyses revealed no asso- 
ciations between OCS, subthreshold OCD, OCD and gen- 
der, employment status and social class [17]. Significant 
associations between age and subthreshold OCD and OCS 
were found: the  12-month prevalence was lower in  the 
older age group. Additionally, the 12-month prevalence of 
excessive  zeros  (85.8 %  of  subjects  reported  0 days  of 
disability due to physical problems and 98.7 % of subjects 
reported 0 days of disability due to psychological prob- 
lems). These two models led to almost identical results and 
fitted the data equally well (based on the Akaike infor- 
mation  criterion,  AIC).  We  chose  the  Hurdle  model 
because we think that its underlying process is somewhat 
more comprehensible compared with the zero inflated 
negative  binomial  model.  The  hurdle  model  (OR  with 
95 % CI and incidence risk ratio  (IRR) with 95 % CI) 
assumes negative binomial (physical disability) or Poisson 
(psychological disability) distributed outcomes. This model 
accounts not only for the excessive number of zeros 
observed, but also for overdispersion (i.e. the fact that the 
observed variability in the outcome was higher than its 
mean, see e.g. [30]). Hurdle models consist of two parts. In 
the first part, a binomial model is used to model the 
probability of zeros versus non-zeros. In the second part 
that deals with the non-zero counts and which is hence 
often called the ‘‘count model’’, a Poisson or a negative 
binomial model is used (depending on whether the counts 
are over dispersed or not). As only non-zero values are 
considered in this second part, this model is zero-truncated 
[31]. 
Our model contained the two factors OCS and physical 
disease plus the interaction between the two. For both 
factors we were thus able to test (1) whether they had an 
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impact on the probability of physical or psychological 
disability and (2) whether they affected the number of days 
of disability among those subjects who have reported at 
least  1 day  of  disability.  The  interaction  thereby  tested 
whether subjects having both OCS and physical disease 
were (1) at a particularly high risk of physical or psycho- 
logical impairment and (2) if so, how strongly. For calcu- 
lating the hurdle model we used the software MPlus 
(version 6) [32]. 
To check for biological interaction as described by Roth- 
man [33], i.e. whether the combined effect of both factors OCS 
and physical disease is larger than the sum of the individual 
effects of these two factors, denoting deviation from additivity 
in disease risks, we additionally calculated the relative excess 
risk due to interaction (RERI), the attributable proportion due 
to interaction (AP) and the synergy index (S) [34], using the 
software R (version 2.14) [35]. Absence of biological inter- 
action thereby suggests independence of OCS and physical 
disease as risk factors of disability. !!
Results !
12-month prevalence !
The 12-month prevalence rate was 8.3 % for OCS, and 
5.2 %  for  the  combined  OCD  and  subthreshold  OCD 
(Table 1). Among physical diseases, the highest 12-month 
prevalence   rate   was  detected   for  arthritic   conditions 
(25.9 %), the lowest for neurological diseases (0.5 %). !
Associations of physical diseases and OCS, 
subthreshold OCD/OCD !
Significantly higher prevalence rates in subjects with OCS 
were  found  for  allergies  (OR  1.6;  95 %  CI  1.1–2.8), 
migraine (OR 1.9; 95 % CI 1.4–2.7) and thyroid diseases 
(OR 1.4; 95 % CI 1.01–2.0) compared to the no OCS group 
(see Table 2). 
The subthreshold OCD/OCD group was associated with 
elevated odds for respiratory diseases (OR 1.7; 95 % CI 
1.03–2.7) and migraine (OR 1.7; 95 % CI 1.1–2.5). 
Disability 
Disability due to physical problems !
We used the two factors OCS (combining both OCS 
groups) and physical disease (which includes any of the 
physical diseases) to analyze the association with disabil- 
ity. As there was no indication of statistical interaction 
between the two factors for both the binomial (p = 0.40) 
and the count model parts (p = 0.77), we reran the model 
without  interaction.  The  binomial  part  of  the  model 
revealed that both OCS and physical disease significantly 
increased the probability of disability (OCS: OR 1.9; 95 % 
CI 1.4–2.5, p <  0.001; physical disease: OR 1.7; 95 % CI 
1.2–2.2, p < 0.001). The count model part of the model 
showed that physical disease significantly increased the 
number of days of disability (IRR 1.6; 95 % CI 1.1–2.2, 
p = 0.008),  whereas  OCS  did  not  (IRR  1.3;  95 %  CI 
0.9–1.8, p = 0.064). 
As shown in Fig. 1, the highest number of days of dis- 
ability due to physical diseases was reported by subjects 
with both OCS and  physical disease (n = 95 (2.74 %), 
M 2.33; 95 % CI 1.61–3.05), followed by subjects with 
OCS only (M 1.10; 95 % CI 0.64–1.55) and by subjects 
with physical disease only (M 1.09; 95 % CI 0.86–1.34). 
Subjects with neither OCS nor physical disease indicated 
the lowest number of days of disability (M 0.50; 95 % CI 
0.3–0.7). There was no indication for the presence of bio- 
logical interaction for any of the three measures (SI, RERI, 
AP; p >  0.05 in each case). !
Disability due to psychological problems !
As there was no indication of statistical interaction between 
the two factors for both the binomial (p = 0.24) and the 
count model parts (p = 0.74) in the disability due to psy- 
chological problems, we again reran the model without the 
interaction. The binomial part of the model revealed that 
both OCS and physical disease significantly increased the 
probability of disability (OCS: OR 3.8; 95 % CI 2.1–6.9, 
p < 0.01;  physical  disease:  OR  3.7;  95 %  CI  1.4–9.8,  
p < 0.01).  Contrary  to  the  disability  due  to  physical 
problems, the count model part of the model revealed that 
there  was  no  significant effect  of  both  factors  on  the 
number of days of disability due to psychological problems 
(p > 0.55 for both model parts). 
As for disability due to physical problems, the highest 
number of days of disability due to psychological problems 
was reported by subjects with both OCS and physical 
disease (n = 19 (0.55 %), M 0.47; 95 % CI 0.17–0.76), 
followed by subjects with OCS only (M 0.14; 95 % CI 
0.03–0.31)  and  by  subjects  with  physical  disease  only 
(M 0.10; 95 % CI 0.05–0.16). Subjects with neither OCS 
nor physical disease indicated the lowest number of dis- 
ability days (M 0.03; 95 % CI 0.00–0.06; Fig. 1). Again, no 
indication for biological interaction was found for any of 
the three measures (SI, RERI, AP; p >  0.05 in each case). !!
Discussion !
To the best of our knowledge, this is the first study that 
analyses the association between OCD and subthreshold 
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Table 2  Associations between 
12 months physical diseases and 
12-months obsessive– 
Physical diseasesa no OCS 
(n = 3,571) 
OCS 
(n = 371) 
Subthreshold OCD/OCD 
(n = 239) 
compulsive symptoms and 
disorder 
!!
Hypertension 
No. % No. (%) OR (CI) No. (%) OR (CI) 
No hypertension (n = 3,372) 2,868 (81.6)   303 (83.5)   1.0 201 (87.4)   1.0 
Hypertension (n = 581) 513 (13.7) 43 (9.7) 0.7 (0.4–1.0) 25 (8.7) 0.6 (0.3–1.0) 
Cardiac diseases 
No cardiac diseases (n = 3,982)   3,394 (95.6)   358 (97.5)   1.0 230 (95.6)   1.0 
Cardiac diseases (n = 100) 89 (2.3) 6 (1.3) 0.6 (0.2–1.4) 5 (2.8) 1.2 (0.4–3.5) 
Respiratory diseases 
No respiratory diseases 
(n = 3,728) 
3,201 (89.6)   321 (87.6)   1.0 206 (85.6)   1.0 
Respiratory diseases (n = 284) 234 (6.8) 26 (6.7) 1.0 (0.6–1.6) 24 (10.8)   1.7  
(1.03–2.7)* 
Gastrointestinal diseases 
No gastrointestinal diseases 
(n = 3,090) 
Gastrointestinal diseases 
(n = 268) 
Diabetes 
!!
2,264 (75.5)   263 (71.3)   1.0 163 (68.3)   1.0 !
215 (6.1) 29 (7.2) 1.3 (0.8–2.0) 24 (8.7) 1.6 (0.9–2.7) 
No diabetes (n = 4,022) 3,430 (96.5)   360 (97.2)   1.0 232 (97.2)   1.0 
Diabetes (n = 115) 102 (2.8) 7 (2.2) 0.8 (0.3–1.8) 6 (2.4) 0.9 (0.3–2.5) 
Arthritic conditions 
No arthritic conditions 
(n = 2,907) 
2,495 (70.7)   248 (69.0)   1.0 164 (70.6)   1.0 
Arthritic conditions (n = 1,107) 938 (25.8)   107 (27.9)   1.1 (0.8–1.5) 62 (25.1)   1.0 (0.7–1.4) 
Allergies 
No allergies (n = 2,682) 2,334 (65.6)   207 (54.3)   1.0 141 (58.3)   1.0 
Allergies (n = 747) 614 (17.3) 81 (23.5)   1.6 (1.1–
2.8)* 
52 (21.9)   1.4 (0.9–2.1) 
Migraine 
No migraine (n = 3,497) 3,016 (86.5)   292 (80.8)   1.0 189 (80.9)   1.0 
Migraine (n = 491) 384 (9.5) 68 (17.0)   1.9 (1.4–
2.7)* 
39 (14.6)   1.7  
(1.1–2.5)* !!
OR odds ratios from logistic 
regression, CI confidence 
Neurological diseases 
No neurological diseases 
(n = 4,114) 
!!
3,517 (99.0)   362 (98.3)   1.0 235 (98.2)   1.0 
intervals, OCS obsessive– 
compulsive symptoms, OCD 
obsessive–compulsive disorder, 
No. unweighted number of 
Neurological diseases (n = 27) 21 (0.5) 4 (0.9) 1.9 (0.6–5.8) 2 (0.9) 2.0 (0.4–9.7) 
Thyroid diseases 
No thyroid diseases (n = 3,451)   2,973 (84.8)   284 (77.6)   1.0 194 (82.1)   1.0 
subjects, % weighted percentage 
* p < 0.05 
a   Subjects reporting physical 
Thyroid diseases (n = 445) 367 (9.7) 49 (12.6)   1.4  
(1.01–2.0)* 
Vascular diseases 
29 (11.0)   1.2 (0.7–1.9) 
diseases during their lifetime 
but not within the past 
No vascular diseases 
(n = 3,351) 
2,859 (81.1)   302 (82.8)   1.0 190 (80.8)   1.0 
12 months were excluded from 
the analyses 
Vascular diseases (n = 536) 459 (12.5) 42 (11.2)   0.9 (0.5–1.4) 35 (13.7)   1.1 (0.7–1.7) 
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Fig. 1  Mean days of disability 
during past 30 days. OCS 
obsessive compulsive 
symptoms; Error bars indicate 
standard errors !!!!!!!!!!!!!!!
forms and physical diseases in a representative community 
sample. 
Our results show that obsessive compulsive symptoms are 
associated with higher prevalence rates of specific physical 
diseases in the general population. These results add to the 
body of literature on the comorbidity of physical diseases 
and other anxiety disorders. In comparison to findings from 
other anxiety disorders, we found associations with migraine 
headaches, allergies and thyroid diseases in OCS and sig- 
nificant associations with respiratory diseases and migraine 
headaches in subthreshold OCD/OCD [2, 9, 10]. Further, our 
analyses revealed that subjects with both OCS and physical 
disease report the highest number of days of disability 
compared to subjects having only OCS (without physical 
disease), only a physical disease or neither of them. 
Different models exist to explain the cooccurrence of 
anxiety disorders and physical diseases: anxiety as conse- 
quent or antecedent factor of a physical disease, third 
variables that lead to the comorbidity or, common genetic, 
environmental or personality factors that contribute to the 
cooccurrence [9]. Even though only few specific hints for 
the explanations of associations between OCS and physical 
diseases exist, these hints can point towards important 
etiological pathways in subgroups of OCD patients and, 
therefore, will be discussed in the following. 
First, defects in serotonin metabolism as possible neu- 
rochemical basis of both migraine and OCD have been 
proposed [36]. An abnormal serotonin function in subjects 
with OCD is one of the most consistent pathophysiologic 
findings [37]. Similarly, serotonin abnormalities have been 
implicated in the pathogenesis of migraine [36, 38]. 
Alternatively it has been proposed that anxiety disorders 
may be involved in peripheral and central mechanisms of 
pain sensitization which contributes to the evolution of 
chronic headaches [39]. Against this background, our 
results can support a suggested role of serotonin in an 
etiological pathway of OCD. 
Second, an increased rate of immune-related symptoms 
among OCD patients has been reported [40]. As a possible 
explanation, one theory suggests that postinfectious auto- 
immune responses might be associated with the develop- 
ment of pediatric OCD, which leads to an increased rate of 
immune-related diseases in adults with OCD [40]. Our 
cross-sectional results match with this theory, as we found 
increased rates of allergies in subjects with OCS. Studies 
showed that especially immune responses to streptococcal 
infections may be relevant for the etiology of OCD [41]. 
Our analyses support a suggested involvement of immune 
responses that may be relevant in the etiology of a sub- 
group of OCD. 
Third, the association between asthma and anxiety dis- 
orders, especially in panic disorder, is well established [42, 
43]. Explanations range from hyperventilation that is 
commonly associated with anxiety disorders, subjective 
psychological disturbance which could lead to enhanced 
bronchoconstriction to biological effects of anxiety on 
immunological or biological factors [44]. Specific expla- 
nations of the association between OCD and respiratory 
diseases lack, however. Therefore, we can only speculate 
that comparable to other anxiety disorders, subjects with 
OCD could have an altered symptom perception leading to 
enhanced awareness of breathlessness and bronchocon- 
striction and therefore to asthma-like symptoms. Despite 
that no specific explanation for this association exists, our 
results nevertheless show that an involvement of the 
respiratory tract may be important in OCD. 
Fourth, pervasive evidence documents the relationship 
between thyroid diseases and mental symptoms such as 
impairment of cognitive functions or behavioral and mood 
disturbances [45, 46]. Concerning OCD, some observations 
of increased rates of obsessive–compulsive symptoms in 
subjects with thyroid disease have been found [46]. As an 
explanation, common biochemical abnormalities that play 
a role for both thyroid diseases and OCD may exist [46]. A 
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diminished thyrotropin releasing hormone (TRH) response 
to a TRH stimulation was detected in subjects with OCD, 
also [47] suggesting an alteration in the serotonergic sys- 
tem, as a decreased central serotonergic activity is associ- 
ated with blunted TSH response [47]. The increased rates 
of thyroid diseases in our analyses support the hypothesis 
of an alteration of the hypothalamic-pituitary-thyroid axis 
in the pathophysiology of OCD, too. 
Fifth, it could be suggested that certain behaviors that 
occur in OCD increase the vulnerability to develop a 
physical disease. As a lack of exercise has been associated 
with anxiety disorders [48] and physical inactivity is 
associated with many chronic physical diseases such as 
cardiovascular diseases or diabetes [49], it could be sug- 
gested that subjects with OCD are at increased risk to 
develop physical illnesses through physical inactivity. 
Further, it has been shown that cleaning activities related to 
exposure to certain cleaning products in the household are 
associated with asthma [50]. Extensive hand washing or 
cleaning can be a symptom of OCD. Through exposure to 
poisonous cleaning agents this could lead to higher prev- 
alence of respiratory diseases in subjects with OCD. 
Additionally, subjects with OCD avoid uncertainty [51]. 
This might in addition be related to an increased preva- 
lence of physical diseases in these subjects, as isolation 
and, therefore, a lack of exercise may be the consequences. 
Given these etiological considerations, our results may 
be useful to deduce hypotheses concerning the involvement 
of certain physiological factors in the etiology of OCD in 
subgroups of subjects. Future studies are clearly needed to 
replicate these findings. 
As some physical diseases were only associated with 
OCS and not OCD (higher prevalence of allergies and 
thyroid diseases only in OCS) or vice versa, it is possible 
that different etiological factors are related to OCS, sub- 
threshold OCD and OCD. Future studies should, therefore, 
not only include OCD but also subthreshold forms to test 
these hypotheses. 
Besides the documentation of the associations between 
physical diseases and OCS and the deduction of potential 
etiological hypotheses, our analyses show that both sub- 
jects with OCS or physical diseases have an increased 
probability of disability due to psychological or physical 
problems during the past 30 days. Comparable to previous 
studies on anxiety disorders [9] or mental disorders in 
general [13] and physical diseases, the highest number of 
days of disability was reported in the group with both OCS 
and physical diseases. This is supported by previous find- 
ings that subjects with both mental and physical conditions 
are more likely to be severely disabled than those with 
either condition alone [13]. 
Due to the fact that no indication for biological inter- 
action was found between OCS and physical disease, the 
increased disability of subjects affected by both OCS and 
physical disease may be seen as an additive rather than a 
synergistic effect of both disorders. 
The mechanisms leading to this specific increased dis- 
ability are unknown. Research on other anxiety disorders, 
however, suggest that anxiety is associated with poor 
adherence to self-care regimen and increased medical 
complications in patients with chronic medical illness [52]. 
This could lead to decreased active behavioral self-man- 
agement strategies and, therefore, to an increased burden of 
the physical disease in anxiety in general [53] and specif- 
ically in OCD. 
The increased disability in subjects with both OCS and 
physical disease may reflect an increased need of recog- 
nition and treatment of both physical disorder and OCS in 
primary health care. Future studies could additionally 
investigate whether this comorbidity is associated with a 
loss in quality of life. 
The current study has a number of limitations. First, 
the survey is limited to subjects aged 18–65 years, which 
does not enable generalization of the results to younger or 
older subjects. Second, as already mentioned by Sareen 
et al. [9], even though physicians’ diagnoses were used, 
certain diagnoses are more reliant on self-report data (e.g. 
arthritis) than others (e.g. diabetes). That may have led to 
over reporting of physical symptoms in anxious patients. 
Third, due to the cross-sectional nature of the study, it is 
not possible to draw conclusions about the causal nature 
of the associations between OCD or OCS and physical 
diseases. Fourth, although we used a large representative 
sample with 4,181 subjects, the sample size of full 
diagnostic OCD is rather small (n = 38). In addition, the 
combinations between OCD symptoms and physical dis- 
eases led  to  small  cell  sizes (especially  in  cardiac  dis- 
eases, diabetes and neurological diseases). Fifth, it has to 
be considered that comorbidity between OCD and sub- 
threshold forms and other mental disorders has been 
reported [17]. Thus, further investigation is needed to 
examine specificity of the results. 
With these limitations in mind, our community study 
shows that subjects affected by DSM-IV obsessive com- 
pulsive disorder either on the full/subthreshold or even on 
the symptomatic level report higher rates of certain phys- 
ical diseases than subjects without these symptoms. This 
comorbidity is associated with higher impairment than 
either condition alone. 
These findings can be helpful to detect new etiological 
pathways underlying OCD in subgroups of affected sub- 
jects or support the ones suggested in earlier studies. In 
addition, clinicians and doctors in primary care need to be 
sensibilized for these associations to recognize and treat 
both physical disease and OCS to reduce disability in 
affected subjects. 
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Abstract 
 
Objective: Specific phobia is the most prevalent anxiety disorder in the community and is 
associated with substantial impairment. Comorbidity with physical diseases is assumed and 
may provide information about possible etiological mechanisms. However, data are limited 
due to methodological issues, and subtypes have not been investigated yet. We examined the 
association of specific phobia and its subtypes with physical diseases in a representative 
community sample with physician-diagnosed physical diseases and diagnostic criteria of 
specific phobia. 
Method: We used data of the German Mental Health Survey from 4,181 subjects aged 18–65 
years. Specific phobia was diagnosed using M-CIDI/DIA-X interview; physical diseases were 
assessed through a self-report questionnaire and a medical interview. Logistic regression 
analyses adjusted for sex were calculated. 
Results: Specific phobia was associated with cardiac diseases, gastrointestinal diseases, 
respiratory diseases, arthritic conditions, migraine, and thyroid diseases (odds ratios between 
1.49 and 2.53). Among the subtypes, different patterns of associations with physical diseases 
were found. The findings were partially replicated in the Swiss PsyCoLaus Study. 
Conclusions: From our findings etiological mechanisms of specific phobia and physical 
disease can be deduced. As subtypes differed in their patterns of associations with physical 
diseases, different etiological mechanisms may play a role. 
 
Key words: specific phobia, comorbidity, physical diseases, representative survey 
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Introduction 
Specific phobia is the most prevalent anxiety disorder in the community [1,2].  It is 
associated with significant impairment and distress [3] and with a loss of work days [4]. 
Further, specific phobia is a predictor for increased suicidal tendency [5] and it is thought to 
be a risk factor for the later development of other mental disorders such as major depression 
[6,7] or anxiety disorders [8]. Additionally, specific phobia is highly comorbid with other 
mental disorders, especially with anxiety disorders and mood disorders [9,10].  
Research has suggested that besides being comorbid with other mental disorders, 
specific phobia may be highly comorbid with physical diseases, too. Having any anxiety 
disorder during the last year has been associated with neurological, vascular, respiratory, 
gastrointestinal, metabolic, bone, and infectious diseases [11-14]. Further, a longitudinal 
analysis showed that self-reported gastrointestinal disease predicted the onset of specific 
phobia in older adults during the next three years [15]. Subjects with coronary heart disease 
reported elevated levels of phobic anxiety [16] and phobic anxiety is associated with cardiac 
mortality [17]. Among men with high levels of phobic anxiety, an increased prevalence rate 
of Parkinson’s disease was found compared to men with low levels of phobic anxiety [18]. 
Further, a review revealed that subjects with chronic obstructive pulmonary disease reported a 
prevalence of 10–17% of specific phobia [19]. Community studies in addition found an 
association between specific phobia and migraine [20], respiratory diseases [11], ulcer [21], 
vascular diseases [22] and heart diseases [23].  
Most research has suggested a link between specific phobia and physical diseases. 
However, there are methodological issues that limit the generalizability of the findings. First, 
not all studies used Diagnostic and Statistical Manual of Mental Disorders (DSM) [24] or 
International Classification of Diseases (ICD) [25] diagnostic criteria of specific phobia. 
Second, the physical diseases were mainly assessed by self-report rather than diagnosed by a 
!! '!
physician. Third, most studies focused on one specific physical disease and therefore provide 
limited information on the association with different physical diseases.  
Knowledge of the comorbidity of specific phobia and physical diseases could 
influence research on the etiology of both physical diseases and specific phobia through the 
detection of possible etiological mechanisms. It is also relevant because some studies have 
suggested that anxiety can complicate the treatment of chronic medical diseases and may 
therefore be associated with worse treatment outcomes [26,27]. 
To the best of our knowledge, no study has evaluated the association between 
subtypes of specific phobia and physical diseases. This comorbidity might differ, given that 
the different subtypes of specific phobia show different comorbidity patterns with other 
mental disorders [28-30]: Youths with natural phobias reported more depressive symptoms 
and showed higher prevalence rates of other anxiety disorders than youths with animal 
phobias [31]; situational phobia was associated with more panic attacks than other specific 
phobia subtypes [30]; and individuals with blood-injection phobia had a higher prevalence of 
marijuana abuse, depression, panic disorder, obsessive-compulsive disorder, or social phobia 
compared to individuals without blood-injection phobia [30,32,33]. Further, some evidence 
suggests physical discrepancies among subtypes of specific phobia. Subjects with different 
subtypes differ in their physiological fear response [30]: Blood-injection phobia is associated 
with vasovagal fainting, whereas other phobias are not [32]. Differences in the neural 
response patterns between blood-injection phobia and animal phobia have been suggested, too 
[34,35]. Additionally, subjects with natural environment phobia reported more somatic 
symptoms than subjects with animal phobia [31]. The comorbidity pattern of subtypes of 
specific phobia and physical diseases could be similarly different. Analyses addressing 
similarities and differences among specific phobia subtypes are important to elucidate 
potential etiological pathways. However, no study to date has analyzed the association 
between subtypes of specific phobia and physical diseases. 
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Aims of the Study 
The aim of our study therefore was to analyze the association of DSM-IV specific 
phobia and its subtypes and a broad range of physical diseases in the German Health 
Interview and Examination Survey, Mental Health Supplement (GHS-MHS). We addressed 
the methodological limitations reported above by using a wide range of physician-diagnosed 
physical diseases and specific phobia assessed by a well-validated structured interview. 
Further, we aim to replicate the findings in a separate data set, the baseline investigation of 
the PsyCoLaus Study. 
 
Materials and Methods 
Design and Sample of the GHS-MHS 
The GHS-MHS, conducted in 1997, was the first nationwide cross-sectional study for 
medical and social assessments in Germany. The GHS-MHS was commissioned by the 
German Ministry of Science, Research and Education and approved by the relevant 
institutional review board of the Robert Koch Institute (Berlin, Germany). The aim of the core 
study was the assessment of sociodemographic characteristics, physical diseases, 
impairments, and health-care utilization in a representative community sample of 7,124 
subjects ages 18–79 years (overall response rate 61.5%). The sample was stratified and 
randomized from 113 communities throughout Germany with 130 sampling units (step 1: 
selection of communities, step 2: selection of sampling units, step 3: selection of inhabitants) 
[2,36]. The data were weighted and confidence intervals were calculated by the Huber–White 
sandwich method to account for the weighting scheme as well as the stratified sampling 
design [36].  
Mental disorders were assessed in a two-stage design: The first stage entailed the 
administration of a 12-item screening questionnaire for mental disorders at the end of the 
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medical examination of the core survey (the Composite International Diagnostic Screener) 
[37]. The second stage involved the administration of a structured psychopathological 
interview, the Munich Composite International Diagnostic Interview (DIA-X/M-CIDI) to all 
core survey respondents who had been screened positive for a mental disorder and to a 
random sample of 50% who screened negative [37]. This subsample of the GHS is the sample 
of the Mental Health Supplement and included 4,181 subjects aged 18–65 years. The M-CIDI 
interview was completed by 87.6% of the subjects (conditional response rate). All subjects 
gave their written informed consent. Further descriptions of aims, design, and methods as well 
as sociodemographic characteristics of the whole GHS-MHS sample can be found elsewhere 
[36]. 
Specific Phobia in the GHS-MHS 
The fully structured DIA-X/M-CIDI interview was used for the diagnostic 
assessments in the GHS-MHS [38] covering both DSM-IV and ICD-10 criteria. Through the 
structured interview symptoms, syndromes, onset, duration and severity were assessed. 
Trained psychologists and physicians conducted the interview [36]. The DIA-X/M-CIDI 
diagnostic algorithms were used to obtain the diagnostic findings reported in this paper [39]. 
There was substantial test–retest reliability (kappa values between 0.56 and 0.81) [40]; the 
sensitivity of the DIA-X/M-CIDI diagnoses ranges from 87.5% to 100%, their specificity 
from 71.2% to 100% [41]. The validity of the full diagnoses ranges from moderate to 
excellent when compared to diagnoses made by independent treating physicians in a sample 
of randomly chosen patients [41].  
We used the 12-month DSM-IV diagnosis of specific phobia. Additionally, the 12-
month diagnoses of the following subtypes of specific phobia were used: the animal subtype 
(referring to fear related to insects, snakes, birds, or other animals), the natural subtype 
(referring to fear related to height, storm, water), the blood-injection subtype (referring to fear 
related to seeing blood, injection, going to the dentist or hospital), the situational subtype 
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(referring to flying in a plane, being in a small closed room, in a cellar, tunnel, or elevator), 
and the other subtype (referring to any other specific fear not matching any other subtype). 
Physical Diseases in the GHS-MHS 
 Physical diseases were assessed by a self-report questionnaire and a standardized 
computer-assisted medical interview by a general practice physician. Using the information 
on physical diseases in the self-report questionnaire, the physician collected data on lifetime 
prevalence, 12-month prevalence, and point prevalence (4 weeks) of 44 physical diseases 
[36]. Blood pressure and anthropometric measurements were conducted and blood and urine 
samples were collected. Diagnoses were then supplemented and revised based on these 
laboratory analyses [36]. The present analyses are based on the physicians’ diagnoses during 
the medical interview.  
Replication Study 
Design and Sample of the PsyCoLaus Study 
 As a replication study, we used the baseline investigation of the CoLaus/PsyCoLaus 
cohort study [42,43]. CoLaus/PsyCoLaus conducted in Lausanne, Switzerland, was designed  
to study mental disorders and cardiovascular risk factors in the general population. The 
subjects aged 35-75 years were randomly selected through the population register of the city 
of Lausanne. All participants of the somatic investigation (CoLaus) aged between 35 and 66 
years were asked to also undergo a comprehensive psychiatric evaluation (PsyCoLaus), 
resulting in a subsample of 3720 subjects (response rate: 67%) [43]. The psychiatric 
assessment took place between 2004 and 2008.  
Specific Phobia in the PsyCoLaus Study 
 The psychiatric evaluation in PsyCoLaus was based on the French version of the semi-
structured Diagnostic Interview for Genetic Studies (DIGS; [44,45]), which elicits DSM-IV 
axis I criteria and suicidal behavior and extensive information on the course and chronology 
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of comorbid conditions. As the phobia section of the original DIGS interview was brief [45] it 
was replaced by the chapter from the semi-structured Schedule for Affective Disorders and 
Schizophrenia – Lifetime Version (SADS-LA) [46,47]. The semi-structured interview 
revealed excellent inter-rater and fair to good test-retest reliability for major mood and 
psychotic disorders [48,49]. Regarding anxiety disorders, applying the French translation of 
the SADS-LA, Leboyer et al. [45] found satisfactory test-retest reliability (mean interval 3.2 
months) for panic disorder/agoraphobia (Yule's Y = 0.43), GAD (Yule's Y = 0.61) and phobic 
disorders (Yule's Y = 0.66). The Yule coefficient for the overall category of anxiety disorders 
was 0.49. Our own reliability study [49], based on a sample of 136 patients who also 
completed the combined DIGS – SADS-LA section for specific anxiety disorders, revealed 
perfect inter-rater agreement for all specific anxiety disorders except for agoraphobia (Yule's 
Y = 0.96). The Yule's Y coefficients for the 6-week test-retest reliability were 0.58 for panic 
disorder, 0.55 for agoraphobia, 0.44 for social phobia, 0.77 for specific phobia and 0.64 for 
OCD. Regarding GAD, no test-retest agreement was obtained.   
During the interview, the subjects were asked if they had experienced symptoms of 
anxiety during certain situations related to the DSM-IV subtypes of specific phobia during 
their lifetime (e.g. “Did you feel anxious when you were flying in a plane?” or “Did you feel 
anxious when you were facing a certain animal?”). Subtypes were then derived from the 
information collected during the interview. For our analyses, the following subtypes were 
created based on DSM-IV criteria (comparable to those of the GHS-MHS): animal, natural, 
situational, blood-injection and the other subtype. As the ages of onset and offset of each 
disorder were assessed, 12 month prevalence of specific phobia and its subtypes could be 
established. 
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Physical Diseases in the PsyCoLaus Study 
 Cardiovascular and metabolic diseases were assessed during the physical CoLaus 
evaluation through a medical interview, physical examinations and blood and urine tests. 
Moreover, in the medical part of the DIGS interview during the psychiatric evaluation 
information was collected on additional physical lifetime diseases.  
For the present analyses, we used data from the CoLaus and PsyCoLaus Studies. 
Cardiac diseases and vascular diseases were diagnosed during the CoLaus Study by an 
adjudication committee according to the latest diagnostic criteria, and diagnoses of 
hypertension and diabetes were based on measurements of blood pressure and fasting glucose 
[42]. For the other groups of diseases data stemmed from the medical part of the psychiatric 
interview. To enable comparison with the GHS-MHS, the same groups of physical diseases 
were built. However, in the groups of cardiac diseases, arthritic conditions and vascular 
diseases not all or different physical diseases were assessed among these groups in both 
studies (as indicated in table 1). The Ethics Committee of the University of Lausanne 
approved both the physical (CoLaus) and psychiatric (PsyCoLaus Study) evaluation. All 
subjects gave their written informed consent [43].  
 
Statistical Analyses 
 Logistic regression analyses were used to evaluate the association of specific phobia 
and physical diseases in both the GHS-MHS and the PsyCoLaus Study (specific phobia as 
predictor, physical diseases as outcome). As specific phobia and physical diseases were both 
associated with sex, the associations were controlled for sex. We considered a p value <0.05 
as statistically significant. The analyses in the GHS-MHS study were carried out using 
STATA 11.0 [50]. The analyses in the PsyCoLaus Study were carried out using SPSS version 
20 [51].  
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Results  
The 12-Month Prevalence of Specific Phobia and Physical 
Diseases in the GHS-MHS 
In the GHS-MHS, the 12-month prevalence of specific phobia was 7.6%, as shown in 
Table 1. The most prevalent subtype of specific phobia was the situational subtype (1.8%), 
and the other subtype was the least prevalent (0.08%). The most prevalent physical diseases 
were arthritic conditions with a 12-month prevalence of 25.9%, followed by allergies 
(18.1%). The least prevalent physical diseases were neurological diseases (0.5%). 
Association Between Specific Phobia and Physical Diseases in the 
GHS-MHS 
As shown in Table 2, having any specific phobia was associated with cardiac diseases, 
gastrointestinal diseases, respiratory diseases, arthritic conditions, migraine, and thyroid 
diseases (odds ratios [ORs] ranging between 1.49, 95% CI [1.15–1.92], for arthritic 
conditions and 2.53, CI [1.73–3.69], for gastrointestinal diseases). Additionally, having any 
specific phobia was associated with any physical disease (OR=1.87, [1.30–2.68]). 
Among subtypes, the situational subtype was associated with the most (4 of 10) 
physical diseases, whereas only one association was found between the natural subtype 
(migraine, OR=2.40, 95% CI [1.29–4.45]) and the blood-injection subtype (respiratory 
diseases, OR=2.14, 95% CI [1.05–4.36]) and physical diseases. Gastrointestinal diseases, 
respiratory diseases, migraine, and thyroid diseases were all associated with two subtypes. 
Replication Analysis  
 In the CoLaus/PsyCoLaus Study, any specific phobia was associated with 
gastrointestinal, respiratory, arthritic conditions, allergic diseases and migraine (ORs ranging 
between 1.30, 95% CI [1.04–1.63], for arthritic conditions and 1.68, 95% CI [1.33–2.13], for 
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migraine). Further, having any specific phobia was associated with having any physical 
disease (OR=1.34, 95% CI [1.07–1.68]). 
 Among subtypes, the animal and natural subtype were associated with respiratory 
diseases (animal: OR=1.62, 95%CI [1.02–2.55]; natural: OR=2.36, 95%CI [1.16–4.82]) and 
migraine (animal: OR=1.71, 95% CI [1.09–2.69]; natural: OR=2.38, 95%CI [1.16–4.85]). 
Additionally, the natural subtype was associated with having any physical disease (OR=3.03, 
95% CI [1.06–8.57]; No other associations were found between subtypes of specific phobia 
and physical diseases in the PsyCoLaus Study. Results of the PsyCoLaus data are available on 
request. 
 
Discussion 
The aim of our study was to determine the association between specific phobia and its 
subtypes and physical diseases in a general population sample to extend information from 
earlier studies by using improved methods (physician-diagnosed physical diseases, 
standardized diagnostics of specific phobia, a wide range of physical diseases assessed within 
one sample). Our study suggests an association of specific phobia and several physical 
diseases in the community. In line with earlier studies, we found an association between 
specific phobia and respiratory diseases [11,52], heart diseases [16,17], vascular diseases [22] 
and cardiac diseases [23]. An association with gastrointestinal diseases has also been found, 
but in comparison to our study the association did not remain significant after adjusting for 
sex [15]. Additionally, we found an association between specific phobia and arthritic 
conditions, migraine, and thyroid diseases. We could replicate the associations between any 
specific phobia and gastrointestinal diseases, respiratory diseases, arthritic conditions and 
migraine in the PsyCoLaus Study. Associations with these physical diseases have already 
been documented within the GHS-MHS for the group of anxiety disorders [11]. 
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As this is cross-sectional data, the temporal sequence of specific phobia and physical 
diseases cannot be determined and different models can be considered for the explanation of 
the comorbidity (specific phobia may be an antecedent or a consequent factor of a specific 
physical disease; there may be common biological or social factors that increase the risk of 
having both specific phobia and physical diseases; or a third variable may contribute to the 
comorbidity through an indirect mechanism). Even though the temporal sequence cannot be 
determined, these analyses can contribute to the deduction of possible etiological pathways of 
both specific phobia and physical diseases.  
It has been suggested that certain pathophysiological mechanisms related to affective 
and anxiety disorders, such as sympathoadrenal hyperactivity, reduced heart-rate variability, 
heightened platelet activity, and endothelial dysfunction, may be of interest in the etiology of 
heart diseases, too [23]. Additionally, ventricular arrhythmia and hyperventilation causing 
coronary spasm have been named as possible mechanisms by which phobic anxiety and 
therefore specific phobia cause coronary heart disease [16,53].  
As a plausible explanation for the comorbidity of gastrointestinal and anxiety 
disorders it has been suggested that the pain or functional limitation of gastrointestinal disease 
could lead to increased feelings of anxiety [54] or that anxiety could lead to an irritation of the 
gastrointestinal system, leading to a gastrointestinal disease [54]. It has also been shown that 
the neurotransmitter serotonin, which is implicated in anxiety disorders in general and 
specifically in specific phobia [55], is also known to affect the gastrointestinal system [56].   
Asthma may, on the one hand, increase the level of anxiety because asthma can be a 
life-threatening condition [52]. Presuming a vulnerability-stress model [57], the probability 
for the development of an anxiety disorder such as specific phobia may increase through such 
a stressful condition. On the other hand, it has been shown that asthma medications have 
some anxiogenic properties [52,58] and it could be that subjects with high levels of anxiety 
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overuse these medications and this may lead to exacerbation of the anxiety symptoms and 
therefore to a full diagnosis of specific phobia. 
Arthritic conditions have mainly been associated with depression, but anxiety 
disorders seem to be rather common in subjects with arthritis, too [59]. It has been reported 
that subjects with arthritic conditions may restrict their physical activity and therefore 
increase their risk for a mental disorder such as specific phobia [60]. Further, certain 
cytokines that increase during the treatment of arthritic conditions may be associated with 
mental disorders [60], and a decrease in immunoglobulins may be associated with anxiety 
[60]. 
Several studies have discussed the association of migraine and psychopathology 
[20,61,62]. Psychosocial factors related to stress and therefore specific phobia can act as a 
trigger for migraine [20]. Additionally, a diminished serotonin level, which is also associated 
with anxiety disorders, has been detected in subjects with migraine [61]. Further, 
psychosocial factors such as avoidance of certain situations that trigger migraine may increase 
the anxiety sensitivity [61].  
An increased rate of subjects with specific phobia has been documented in thyroid 
disease compared to subjects in the general population [63,64]. However, studies on possible 
common pathways are lacking. Common neurochemical abnormalities have been identified as 
a possible link between anxiety and thyroid disease [63]. 
Beside the association between specific phobia and physical diseases, different 
patterns of associations between the subtypes of specific phobia and physical diseases have 
been detected. Most associations were found between the situational subtype and physical 
diseases. This is in line with a finding from an earlier study that situational phobia has higher 
rates of comorbid psychopathology than animal and natural phobias [65]. Another study 
found more somatic symptoms in subjects with natural phobia compared to subjects with 
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animal phobia [31], which might suggest a somatic vulnerability of the natural subtype. In our 
study, however, the natural subtype was only associated with one physical disease.  
The different patterns of associations between the subtypes and physical diseases may 
point toward different etiological mechanisms that need to be addressed in future studies. As 
blood-injection phobia is—alone of the subtypes—associated with vasovagal fainting [30], it 
could be, for instance, that people with this phobia profit from their rather low blood pressure, 
leading to a reduction of their risk for certain physical ailments, such as cardiovascular 
diseases or hypertension.  
The current study has a number of limitations. First, the subjects assessed were 
between 18 and 65 years of age. Therefore the results cannot be generalized to younger or 
older subjects. Second, some diagnoses may rely more on self-report data (e.g. arthritis) than 
other (e.g. diabetes) [11]. This could lead to over-reporting of certain symptoms in subjects 
with specific phobia. Third, no conclusions concerning the causal nature of the associations 
between specific phobia and physical diseases can be drawn. Fourth, although the sample size 
is 4,181 subjects, the combination of physical diseases and specific phobia led to relatively 
small cell sizes, especially in the subtype analyses in the GHS-MHS. Fifth, the comparability 
of the GHS-MHS and PsyCoLaus study was limited with respect to methodology used and 
data collected, as different timeframes (12 months vs. lifetime diagnosis of physical diseases) 
and different age ranges of subjects (18–65 vs. 35–66 years) were used. Further, not all 
physical diseases were assessed in both studies. Accordingly, it was not surprising that the 
results from the GHS-MHS study could be partially replicated. Several associations were only 
observed in the GHS-MHS study, which could be attributable to the younger age of the 
sample. Indeed, in the older CoLaus/PsyCoLaus sample the prevalence of almost all physical 
diseases was considerably higher than in the GHS-MHS study and it is therefore possible that 
an increased number of age related factors predisposing to these diseases could have blurred 
their association with specific phobia in CoLaus/PsyCoLaus.  
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Despite these limitations, our study shows that specific phobia is highly comorbid with 
different physical diseases. Moreover, the different subtypes show different patterns of 
comorbidity with physical diseases in a community sample.  
The comorbidity of specific phobia and physical diseases has been rarely evaluated 
until now. However, the findings in our community sample support the importance of further 
research within this field, as the comorbidity may influence the burden of subjects affected 
and treatment outcome.  
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Tables 
Table 1. Frequency of Specific Phobia and Its Subtypes and Physical Diseases in the GHS-MHS 
(12 Months) and the PsyCoLaus Study (12 Months for Specific Phobia and Lifetime for Physical 
Diseases). !!
Phobia/Disease GHS-MHS PsyCoLaus 
No. % No. % 
Any specific phobiaB 388 7.6 518 13.9 
SubtypesS     
  Animal subtype 68 1.5 112 3.0 
  Natural subtype 75 1.4 37 1.0 
  Blood-injection subtype 64 1.5 18 0.5 
  Situational subtype 89 1.8 48 1.3 
  Other subtype 3 0.08 10 0.3 
Hypertension 581 13.1 1,110 29.8 
Cardiac diseases (heart circulation disturbances, narrowing 
of the coronary vessels, angina pectoris, cardiac infarct, 
heart weakness, heart insufficiency)c 
100 2.2 199 5.3 
Respiratory diseases (asthma, chronic bronchitis) 284 7.0 572 15.3 
Gastrointestinal diseases (ulcer, gastritis) 268 6.3 252 6.7 
Diabetes (with or without insulin treatment) 115 2.7 194 5.2 
Arthritic conditions (wear and tear type, inflammatory 
diseases of the joints)d! 1,107 25.9 773 20.8 
Allergies (hay fever, allergic eczema, allergic hives, 
neurodermatitis, food allergy, allergic conjunctivitis) 
747 18.1 1,018 27.3 
Migraine headaches 491 10.3 562 15.2 
Neurological diseases (epilepsy, Parkinson’s disease, 
multiple sclerosis) 
27 0.5 94 2.5 
Thyroid diseases 445 10.0 164 4.4 
Vascular diseases (stroke, brain circulation disturbance, 
leg circulation disturbance, artery occlusion, varicose 
veins, vein thrombosis)e 
536 12.4 303 8.2!
Note. No.: Unweighted number of subjects; %: Percentage (in the GHS-MHS: weighted percentage); GHS-
MHS: German Health Survey, Mental Health Supplement aIncluding animal, natural, blood-injection, situational, 
or any other subtype. bsubjects did not fulfill the criteria of any other subtype. cIn the PsyCoLaus Study: 
coronary artery disease, angina, myocardial infarct, percutaneous coronary intervention, coronary artery bypass 
graft, pacing, heart failure, valvular heart disease, cardiomyopathy. dIn the PsyCoLaus Study: rheumatoid 
arthritis, osteoarthritis, arthritis. eIn the PsyCoLaus Study: arrhythmia, stroke, peripheral artery diseas
!! ""!
Table 2. Odds Ratios and Confidence Intervals of Physical Diseases (12 Months) for Specific Phobia and Its Subtypes (12 Months) Compared to a Reference Group 
That Had no Specific Phobia During the past 12 Months in the German Health Survey – Mental Health Supplement (N=4,181). 
 
Note. CI confidence interval, DSM-IV Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; NOS not other specified, OR Odds Ratio, n unweighted number of subjects, % weighted percentage, adjusted for sex. 
* p<0.05, 1empty cell size, a Subjects did not fulfill the criteria of any other subtype  
 
Phobia Physical disease 
 Hypertension 
(n=581) 
Cardiac 
diseases 
(n=100) 
Gastro- 
intestinal  
diseases 
(n=268) 
Respiratory 
diseases 
(n=284) 
Diabetes 
(n=115) 
Arthritic  
conditions 
(n=1,107) 
Allergies 
(n=747) 
Migraine 
(n=491) 
Neurological 
diseases 
(n=27) 
Thyroid 
diseases 
(n=445) 
Vascular 
diseases 
(n=536) 
Any physical 
disease 
(n=2,602) 
Any specific 
phobia 
(n=388) 
1.22 (0.88–1.67) 
(n=69) 
1.94 (1.05–3.57)* 
(n=16) 
2.53 (1.73–
3.69)* 
(n=47) 
2.20 (1.52–
3.16)* 
(n=49) 
1.26 (0.63–
2.51) 
(n=12) 
1.49 (1.15–
1.92)* 
(n=131) 
1.29 (0.94–
1.76) 
(n=80) 
1.99 (1.47–
2.69)* 
(n=78) 
0.68 (0.09–4.95) 
(n=1) 
 
1.72 (1.24–
2.37)* 
(n=69) 
1.17 (0.83–1.65) 
(n=62) 
 
1.87 (1.30–2.68)* 
(n=289) 
 
Animal subtypea 
(n=68) 
0.88 (0.39–1.97) 
(n=8) 
2.76 (0.82–9.17) 
(n=3) 
3.53 (1.73–
7.19)* 
(n=14) 
2.52 (1.10–
5.76)* 
(n=8) 
1.92 (0.45–
8.15) 
(n=2) 
0.93 (0.48–
1.78) 
(n=15) 
2.02 (1.008–
4.05)* 
(n=18) 
1.54 (0.79–
2.99) 
(n=13) 
4.07 (0.52–
31.37) 
(n=1) 
1.44 (0.73–2.86) 
(n=13) 
1.04 (0.49–2.20) 
(n=10) 
1.24 (0.53-2.87) 
(n=48) 
Natural subtypea 
(n=75) 
1.45 (0.75–2.80) 
(n=15) 
2.28 (0.76–6.87) 
(n=4) 
2.53 (0.99–6.41) 
(n=6) 
1.66 (0.62–
4.38) 
(n=6) 
0.86 (0.19-
3.81) 
(n=2) 
1.55 (0.90–
2.65) 
(n=26) 
1.28 (0.61–
2.65) 
(n=13) 
2.40 (1.29–
4.45)* 
(n=17) 
-1 1.41 (0.70–2.80) 
(n=13) 
1.74 (0.89–3.40) 
(n=16) 
2.02 (0.99–4.09) 
(n=58) 
Blood-injection 
subtypea 
(n=63) 
 
0.89 (0.38–2.06) 
(n=8) 
2.05 (0.47–8.80) 
(n=2) 
2.20 
 (0.89–5.39) 
(n=6) 
2.14 (1.05-
4.36)* 
(n=10) 
1.03 (0.14–
7.49) 
(n=1) 
1.25 (0.68–
2.25) 
(n=19) 
0.84 (0.40–
1.73) 
(n=9) 
1.60 (0.71–
3.55) 
(n=8) 
-1 1.56 (0.64–3.73) 
(n=7) 
0.75 (0.30–1.85) 
(n=6) 
0.99 (0.50–1.95) 
(n=35) 
Situational 
subtypea 
(n=88) 
1.49 (0.86–2.56) 
(n=22) 
1.81 (0.64–5.14) 
(n=5) 
2.35 (1.14–
4.85)* 
(n=10) 
1.63 (0.77–
3.44) 
(n=9) 
1.17 (0.40–
3.44) 
(n=4) 
1.82 (1.12–
2.93)* 
(n=34) 
0.84 (0.46-
1.52) 
(n=17) 
2.08 (1.16–
3.70)* 
(n=18) 
-1 2.55 (1.42–
4.57)* 
(n=21) 
0.71 (0.36–1.37) 
(n=13) 
1.70 (0.76-3.80) 
(n=69) 
Othera 
(n=3) 
-1 -1 -1 -1 -1 -1 -1 -1 -1 29.91 (2.36-
378.42)* 
(n=2) 
-1 1.55 (0.12–19.62) 
(n=2) 
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Objective: Infectious diseases and anxiety disorders are common and both are associated 
with substantial burden to individual, families, and society. A better understanding of their 
association may be helpful in explicating  possible etiological mechanisms related to both. 
The goal of the current study was to investigate the relationship between specific infectious 
diseases and anxiety disorders among  adults  in the community, and to examine whether 
the co-occurrence of the two is associated with poorer quality of life compared to subjects 
with one or neither condition. !
Methods: We used data from the 1998 German Mental  Health survey  with 4181 subjects 
aged  18–65.  Various infectious diseases (lifetime) and  health-related quality of life were 
assessed via self-report questionnaires and anxiety disorders (past 12-months) were diag- 
nosed using  M-CIDI interviews. Logistic  regression analyses were used to evaluate the 
association between infectious diseases and anxiety disorders; a linear model adjusted for 
sex was used to examine whether comorbidity of infectious diseases and anxiety disorders 
was  associated with quality of life. !
Results: Whooping  cough  [odds  ratio (OR) = 1.69,  95%  confidence intervals  (CI) = 1.36– 
2.09],  scarlet fever   (OR = 1.31,   95%   CI = 1.02–1.68), and  diphtheria   (OR = 1.79,   95% 
CI = 1.21–2.64) were associated with increased prevalence of any anxiety disorder. Subjects 
with both  infectious diseases and anxiety disorders reported lower  levels  of both  mental 
and physical quality of life, compared with subjects with only one or neither condition. !
Conclusion: Extending  prior research, this  study  suggests a relationship between spe- 
cific infectious diseases and  anxiety  disorders in an adult  community sample. Research 
targeting etiological mechanisms related to the interplay between infectious diseases and 
anxiety disorders is warranted. !
Keywords: representative survey, anxiety disorder, comorbidity, infectious diseases, quality  of life !!
INTRODUCTION 
Approximately 26% of the total global burden of disease is attrib- 
utable to infectious diseases (1). Studies have also revealed that 
mental disorders are a leading contributor to the total all cause 
burden of disease worldwide (2, 3). Such rates render the refined 
understanding, treatment, and prevention of both infectious dis- 
ease and mental disorders as important public health goals. Toward 
this end, it is crucial to understand etiological pathways involved 
in disease and associated burden. Importantly, increasing evidence 
points to associations between some infectious diseases and mental 
disorders that may hint at overlapping etiologic pathways. 
Major depressive disorder is associated with streptococcal infec- 
tions (4). Further, severe infections such as hepatitis infections or 
sepsis infections are associated with subsequent mood disorder 
diagnosis in a longitudinal study (5). In addition, studies have 
shown that pre-natal exposure to viruses increases the offsprings 
risk of  unipolar affective disorder (6).  Due to the association 
of infectious diseases and affective disorders, there have been 
efforts to detect potential etiological mechanisms related to both 
infectious diseases and affective disorders (7, 8). 
While much is known about infectious disease and mood disor- 
ders, relatively little has been done to investigating the possibly link 
between infectious disease and anxiety disorders. Some research 
findings suggest that infectious diseases could be related to the 
development of specific anxiety disorders. Among infectious dis- 
eases, childhood group A streptococcal infections appear to be 
associated with obsessive–compulsive disorder and/or tic disor- 
ders (pediatric autoimmune neuropsychiatric disorders associated 
with streptococcal infection or PANDAS) (9) based on the results 
of several studies. Other studies have found increased preva- 
lence rates of posttraumatic stress disorder in HIV positive sub- 
jects across different demographic, cultural, and socioeconomic 
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backgrounds (10). Additionally, anxiety disorders are associated 
with inflammatory markers such as C-reactive protein in men 
(11) and were found to be associated with having experienced 
a common cold during the last 12 months compared to subjects 
without (12). Furthermore, it was found that in older subjects 
with cytomegalovirus (CMV) antibodies, individuals with higher 
CMV specific antibody titers were more likely to be anxious than 
subject with lower CMV antibodies (13). A cross-sectional study 
looking at the association of infections in the first year of life 
(reported by the parents) and anxiety disorders found that there is 
an association between having any infection during the first year 
of life and anxiety disorders (14). However, no differentiation was 
made between different types of infections in this study. Addi- 
tionally, very small cell sizes prohibited more informative analyses 
(14). No prior study has examined the relationship between anx- 
iety disorders and specific infectious disease among adults in the 
community. 
Additionally, research has shown that the comorbidity of anxi- 
ety disorders and physical health problems such as chronic physical 
diseases is related to a decrease in health-related quality of life 
(15). To date, no study has investigated whether the comorbid- 
ity between infectious diseases and anxiety disorders is associated 
with an excess loss of health-related quality of life. 
The goal of the current study was to investigate the relationship 
between infectious diseases and anxiety disorders in a larger cross- 
sectional sample of adults in the community. We also investigated 
whether comorbidity of anxiety disorders and infectious disease is 
associated with an excess loss of health-related quality of life. !
MATERIALS AND METHODS 
DESIGN AND SAMPLE 
Data were drawn from the German Health Interview and Exam- 
ination Survey and its Mental Health Supplement (GHS-MHS) 
conducted in 1997. The German Health Survey (GHS) was the 
first nationwide cross-sectional study for medical and social assess- 
ments in Germany, commissioned by the German Ministry of 
Science, Research and Education, and the Robert Koch Institute 
and authorized by the relevant institutional review board and 
ethics committee. The aim of the core study was the assessment of 
sociodemographic characteristics, physical diseases, impairments, 
and healthcare utilization in a representative community sample of 
7124 subjects aged 18–79 (Overall Response Rate: 61.5%). It was a 
stratified, randomized sample from 113 communities throughout 
Germany with 130 sampling units (sampling steps: 1: selection of 
communities, 2: selection of sampling units, 3: selection of inhab- 
itants) (16, 17). To handle the stratified sampling design the data 
were weighted and confidence intervals (CI) were calculated by 
the Huber–White sandwich method to account for the weighting 
scheme as well as the stratified sampling design (16). 
For the assessment of mental disorders in the GHS-MHS a two- 
stage design was used: The first stage entailed the administration 
of a 12-item screening questionnaire for mental disorders at the 
end of the medical examination of the core survey (CID-S) (18). 
The second stage involved the administration of a structured psy- 
chopathological interview, the Munich Composite International 
Diagnostic Interview (DIA-X/M-CIDI) to all core survey respon- 
dents who had been screened positive for a mental disorder and to a 
random sample of 50% who screened negative (18). This subsam- 
ple of the GHS built the sample of the Mental Health Supplement 
and included 4181 subjects aged 18–65 years. The conditional 
response rate (i.e., subjects who completed the M-CIDI interview) 
was 87.6%. All participants gave their informed consent. Further 
description of aims, design, and methods as well as sociodemo- 
graphic characteristics of the whole GHS-MHS sample can be 
found elsewhere (16). !
MEASURES 
Mental disorders 
For the diagnostic assessments, a modified version of the fully 
structured interview DIA-X/M-CIDI was used (19). The questions 
cover DSM-IV and ICD-10 criteria. The DIA-X interview enables 
the assessments of symptoms, syndromes and onset, duration, and 
severity. The interview was conducted by trained psychologists and 
physicians (20). The DIA-X/M-CIDI diagnostic algorithms were 
used to obtain diagnostic findings reported in this paper (21). The 
test–retest reliability of the DIA-X/M-CIDI was substantial (kappa 
values ranging between 0.56 and 0.81) (20) and the sensitivity of 
the DIA-X/M-CIDI diagnoses ranges from 87.5 to 100%; and their 
specificity from 71.2 to 100% (22). Analyses revealed that the valid- 
ity of the full diagnoses ranges from moderate to excellent when 
compared to diagnoses administered from independent treating 
physicians in a sample of randomly chosen patients (22). 
The present study used the following 12-months DSM-IV 
mental disorders: agoraphobia, social phobia, specific phobia 
(animal, natural environment, blood–injection–injury, situational 
type), panic disorder, generalized anxiety disorder, and obsessive– 
compulsive disorder. We also included panic attacks during the 
last 12 months. !
Infectious diseases 
Subjects were queried via a paper–pencil questionnaire: “which of 
the following infectious diseases did you have during your lifetime: 
diphtheria, whooping cough, measles, mumps, rubella, chicken 
pox, scarlet fever, tuberculosis, dysentery, or typhus?” !
Quality of life 
We used the German version (23) of the well-validated (24–26) SF- 
36 quality of life questionnaire. The SF-36 assesses health-related 
quality  in  eight dimensions during the  past  30 days (physical 
functioning, social functioning, role limitations due  to  physi- 
cal problems, bodily pain, mental health, role limitations due to 
emotional problems, vitality, and general health). Principal com- 
ponent analysis revealed two robust factor dimensions of physical 
and mental health: the Physical Component Score (PCS) and the 
Mental Component Score (MCS) (27). !
STATISTICAL ANALYSES 
Association between infectious diseases and anxiety disorders 
We used logistic regression analyses [odds ratio (OR) with 95% 
CI] to examine associations between infectious diseases (yes/no, 
the predictors in the model) and anxiety disorders (yes/no, the out- 
come in the model). We considered a p value <0.05 as statistically 
significant. As the analyses revealed that there was an association 
between both anxiety disorders and infectious diseases and sex 
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the models were controlled for sex. We additionally built a vari- 
able called any anxiety disorder, which includes any of the anxiety 
disorders. As we had additional lifetime information for panic 
disorder and panic attacks, we checked for an association of these 
variables with infectious diseases. 
We further tested whether subjects with one or more than 
one anxiety disorder report more infectious diseases than subjects 
without any anxiety disorder. As the assumptions (homoscedastic- 
ity and normality) were fulfilled, we set up a linear model with the 
number of anxiety disorders (three categories: none, one, and more 
than one disorder) as independent variable and the mean number 
of infectious diseases (ranging from zero to nine) as dependent 
variable. In all analyses, sex was included as covariate. For all 
analyses, we used the STATA software package, version 11.0 (28). !
Association between comorbidity and quality of life 
To analyze the association between anxiety disorders and infec- 
tious diseases and quality of life we used the two variables anxiety 
disorder (including any of the anxiety disorder) and infections 
(including any of the infectious diseases), both having two levels 
(yes/no). We combined these two variables and built a factor with 
four levels: one level with subjects with no infection and no anxi- 
ety disorder, one with only infection and no anxiety disorder, one 
with no infection but with anxiety disorder, and one level with 
both anxiety disorder and infection. To examine the association 
between this factor and the dependent variable, the PCS and MCS 
of the SF-36, we used a linear model with sex as covariate. For all 
analyses, we used the STATA software package, version 11.0 (28). !
RESULTS 
ASSOCIATION OF INFECTIOUS DISEASES  AND ANXIETY DISORDERS 
As shown in Table 1, most associations (five out of nine) were 
found between whooping cough and 12-month anxiety disorders 
[ORs ranging from 1.52 (95% CI = 1.15–2.00) for simple phobia 
to 2.15 (95% CI = 1.36–3.40) for agoraphobia without panic dis- 
order]. The associations between measles, rubella, chicken pox, 
and anxiety disorders were not  significant. Additionally, most 
infectious diseases (4 out of 10) were associated with agora- 
phobia without panic disorder (ORs ranging from 1.79 (95% 
CI = 1.06–3.00) for mumps and 2.61 (95% CI = 1.001–6.82) for 
tuberculosis), whereas no associations between infectious dis- 
eases and phobic disorder not other specified, social phobia and 
obsessive–compulsive disorder were found. 
Whooping  cough  (OR = 1.69,  95%   CI = 1.36–2.09),  scar- 
let   fever   (OR = 1.31,   95%   CI = 1.02–1.68),   and   diphtheria 
(OR = 1.79, 95% CI = 1.21–2.64) were associated with having any 
12-month anxiety disorder. 
Additional analyses with lifetime diagnoses of panic disorder 
and panic attacks and infectious diseases revealed that whoop- 
ing cough (OR = 1.46, 95% CI = 1.02–2.07), typhus (OR = 4.24, 
95% CI = 1.80–9.97), and diphtheria (OR = 2.39, 95% CI = 1.36– 
4.21) were associated with panic disorder, whereas whooping 
cough (OR = 1.42, 95% CI = 1.09–1.85), scarlet fever (OR = 1.37, 
95%  CI = 1.01–1.86),  dysentery  (OR = 2.41,  95%  CI = 1.04– 
5.56),  typhus (OR = 2.62, 95%  CI  1.21–5.66), and  diphtheria 
(OR = 2.25,  95%  CI = 1.42–3.55)  were  associated  with  panic 
attacks during lifetime. 
As shown in Figure 1, having one or more anxiety disorders was 
associated with an increased number of infectious diseases com- 
pared to no anxiety disorder (mean number of infectious diseases 
with no anxiety disorder: 2.42, 95%  CI = 2.36–2.48; one anxi- 
ety disorder: 2.76; 95% CI = 2.60–2.91; two or more: 2.75; 95% 
CI = 2.51–2.99, z = 2.76, p < 0.006). Contrast analysis in addition 
showed that having more than one anxiety disorder did not fur- 
ther increase the number of infectious diseases relative to having 
one anxiety disorder (z = 0.26, p < 0.798). !
ASSOCIATION  OF COMORBIDITY AND QUALITY OF LIFE 
As shown in Figure 2, subjects with both infectious disease and 
anxiety disorders report a lower level in the MCS (M = 43.6, 95% 
CI = 42.5–44.7) than subjects with only infectious disease (51.6, 
95% CI = 51.3–52.0, z = !14.23, p < 0.000) or neither of them 
(M = 50.5, 95% CI = 49.1–52.0, z = !7.32, p < 0.000). In the PCS 
subjects with only anxiety disorder (M = 42.3, 95% CI = 35.5– 
48.0,  z = !2.09,  p < 0.037)  and  with  both  infectious  disease 
and anxiety disorder (M = 46.2, 95% CI = 45.2–47.1, z = !2.35, 
p < 0.019) report a lower level when compared to subjects with 
neither condition (M = 48.9, 95% CI = 47.2–50.7). 
Additionally, subjects with only anxiety disorder (M = 42.3, 
95%  CI = 35.5–48.0) report a lower quality of life in the PCS 
compared to  subjects with  only  infectious disease (M = 49.6, 
95% CI = 49.2–50.0, z = !2.48, p < 0.013). Further, subjects with 
both  anxiety disorder and infectious diseases (M = 46.2, 95% 
CI = 45.2–47.1) report a lower quality of life in the PCS when 
compared to subjects with only infectious disease (M = 49.6, 95% 
CI = 49.2–50.0, z = !6.61, p < 0.000). All other comparisons 
were not significant. !
DISCUSSION 
This study investigated the associations between infectious dis- 
eases and anxiety disorders in a representative adult community 
sample. The results of this study suggest that specific infectious 
diseases are associated with significantly increased prevalence of 
anxiety disorders, compared with those without infectious dis- 
eases, and that the co-occurrence of the two is associated with 
substantial loss in quality of life. Specifically, our findings revealed 
associations between whooping cough, scarlet fever, and diphthe- 
ria and increased likelihood of having anxiety disorder. Addition- 
ally, associations between whooping cough, mumps, scarlet fever, 
tuberculosis, dysentery, typhus, diphtheria, and specific anxiety 
disorders were found. Our findings are partly in line with an ear- 
lier study suggesting an association between an infection in the 
first year of life and panic disorder, social phobia, and overanxious 
disorder (14). As in that study, we found associations of infec- 
tious diseases and anxiety disorders in general. In contrast, we did 
not find an association between any of the investigated infectious 
diseases and social phobia. 
The findings are based on data from a representative com- 
munity sample and therefore the results are not limited by the 
same biases as in clinical samples. However, due to the cross- 
sectional nature of this study, no conclusions concerning the 
temporal sequence of infectious diseases and anxiety disorders 
can be made. Therefore to explain the observed associations, three 
different models will be considered. 
!!
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Table 1 | Odds Ratios  of infectious diseases (lifetime) for anxiety disorders (12 months) compared to the reference group  that had no indexed anxiety disorder  during the past  12 months 
(N = 4181). !
DSM-IV mental 
disorder 
Whooping 
cough (n = 977, 
Measles 
(n = 2591, 
Mumps 
(n = 2066, 
Rubella 
(n = 1467, 
Chicken pox 
(n = 2390, 
Scarlet fever 
(n = 632, 
Tuberculosis 
(n = 91, 
Dysentery 
(n = 52, 
Typhus 
(n = 48, 
Diphtheria 
(n = 181, ! 23.6%) 63.2%) 48.7%) 35.1%) 58.1%) 14.9%) 2.2%) 0.9%) 1.1%) 4.1%) 
Any anxiety disordera 1.69 (1.36–2.09)* 1.00 (0.78–1.28) 1.13 (0.92–1.40) 0.96 (0.78–1.20) 1.07 (0.84–1.36) 1.31 (1.02–1.68)* 1.51 (0.83–2.73) 1.90 (0.86–4.18) 1.17 (0.54–2.53) 1.79 (1.21–2.64)* 
(n = 727, 14.5%) (n = 220) (n = 458) (n = 377) (n = 265) (n = 430) (n = 128) (n = 18) (n = 12) (n = 11) (n = 49) 
Panic disorder 1.52 (0.97–2.34) 0.68 (0.41–1.13) 0.97 (0.62–1.52) 0.91 (0.58–1.44) 0.89 (0.54–1.45) 1.08 (0.65–1.80) 0.52 (0.07–3.87) 0.82 (0.19–3.48) 0.57 (0.07–4.31) 2.82 (1.48–5.39)* 
with/without agoraphobia 
(n = 121, 2.3%) 
(n = 41) (n = 73) (n = 65) (n = 46) (n = 72) (n = 25) (n = 1) (n = 2) (n = 1) (n = 14) 
Panic attack  (n = 241, 1.49 (1.07–2.06)* 0.91 (0.62–1.34) 1.19 (0.85–1.66) 0.97 (0.69–1.35) 1.17 (0.79–1.72) 1.29 (0.88–1.89) 1.31 (0.52–3.34) 1.21 (0.33–4.35) 0.55 (0.13–2.36) 2.46 (1.46–4.14)* 
4.7%) (n = 76) (n = 149) (n = 130) (n = 89) (n = 149) (n = 47) (n = 6) (n = 4) (n = 2) (n = 22) 
Agoraphobia without 2.15 (1.36–3.40)* 1.81 (0.91–3.60) 1.79 (1.06–3.00)* 1.12 (0.68–1.83) 0.78 (0.45–1.33) 1.97 (1.17–3.33)* 2.61 2.71 (0.69–10.58) 2.12 (0.55–8.13) 1.93 (0.83–4.47) 
panic disorder  (n = 105, 
2.0%) 
(n = 42) (n = 81) (n = 67) (n = 42) (n = 64) (n = 25) (1.001–6.82)* 
(n = 5) 
(n = 4) (n = 3) (n = 8) 
Simple phobia (n = 388, 1.52 (1.15–2.00)* 0.80 (0.59–1.09) 1.00 (0.76–1.30) 1.03 (0.78–1.37) 1.18 (0.86–1.67) 1.18 (0.85–1.63) 1.54 (0.70–3.39) 1.15 (0.37–3.56) 0.96 (0.31–2.96) 1.50 (0.92–2.45) 
7.6%) (n = 111) (n = 244) (n = 196) (n = 146) (n = 234) (n = 65) (n = 9) (n = 4) (n = 4) (n = 26) 
Phobic disorder  NOS 1.49 (0.99–2.24) 1.01 (0.63–1.61) 1.08 (0.73–1.60) 0.86 (0.58–1.28) 0.84 (0.55–1.28) 1.08 (0.66–1.76) 1.81 (0.57–5.73) 2.88 (0.76–10.82) 0.77 (0.17–3.38) 1.56 (0.76–3.17) 
(n = 173, 3.4%) (n = 48) (n = 110) (n = 88) (n = 61) (n = 102) (n = 26) (n = 5) (n = 3) (n = 2) (n = 10) 
Social phobia (n = 94, 1.35 (0.80–2.27) 1.71 (0.85–3.45) 0.71 (0.43–1.18) 0.82 (0.49–1.38) 1.08 (0.56–2.10) 0.64 (0.31–1.34) 0.95 (0.21–4.17) –b 0.24 (0.03–1.77) 1.36 (0.54–3.37) 
1.9%) (n = 26) (n = 55) (n = 45) (n = 33) (n = 55) (n = 10) (n = 2) ! (n = 1) (n = 6) 
Generalized anxiety 1.94 (1.12 –3.35)* 1.28 (0.64–2.54) 1.28 (0.71–2.30) 0.80 (0.44–1.45) 1.40 (0.68–2.85) 1.32 (0.67–2.60) 1.41 (0.33–5.93) 1.62 (0.21–11.97) –b 1.39 (0.31–6.53) 
disorder  (n = 73, 1.5%) (n = 28) (n = 50) (n = 37) (n = 26) (n = 45) (n = 14) (n = 2) (n = 1) ! (n = 2) 
Obsessive–compulsive 1.15 (0.53–2.49) 0.82 (0.35–1.94) 0.78 (0.34–1.76) 0.95 (0.41–2.20) 1.32 (0.51–3.38) 1.10 (0.36–3.27) 1.50 (0.32–6.80) –b –b 2.16 (0.62–7.54) 
disorder  (n = 38, 0.7%) (n = 11) (n = 25) (n = 16) (n = 13) (n = 23) (n = 5) (n = 2) ! ! (n = 3) !
CI, confidence interval; DSM-IV, diagnostic  and statistical manual of mental disorders, fourth edition; NOS, not other specified; OR, odds ratio; n, unweighted number of subjects, % weighted percentage, *p < 0.05, 
adjusted for sex. 
a including any anxiety  disorder during the past 12 months. 
b empty cell size. 
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First, infectious diseases may precede anxiety disorders. 
Through biochemical processes, infections may increase the risk 
of having an anxiety disorder. Some infectious diseases such as 
scarlet fever mainly have their first onset in early childhood (29), 
whereas most anxiety disorders emerge for the first time during 
puberty (17, 30). We might therefore suggest that some infectious 
diseases do emerge before anxiety disorders do. This interpretation 
may be supported by the findings of the above mentioned cross- 
sectional study addressing the relationship of infectious diseases !!!
 !!
FIGURE 1 | Mean number of infectious diseases (lifetime) for subjects 
with  no anxiety disorder, with  one  anxiety disorder, and with  two or 
more  anxiety disorders (12 months). Mean  scores adjusted for sex; n.s. 
not significant,  *p < 0.05, weighted data. 
and anxiety disorders, showing that severe infections during the 
first year of life (reported by the parents) are associated with 
increased anxiety disorders among 9–17-year olds, therefore sug- 
gesting that infections occur before anxiety disorders emerge 
(14). Research suggests that increased concentration of proin- 
flammatory cytokines could contribute to feeling of depression, 
and also anxiety (13). Additionally, it is known that some viral 
infections, such as tuberculosis, can directly affect the brain (31). 
These processes may damage the brain and therefore cognitive 
impairments and behavioral changes can occur (31). Cognitive 
impairment in different domains such as executive functioning or 
visual memory has been found to be common among people with 
anxiety disorders (32) and is thought to reduce coping abilities 
and impact social and occupational functioning (32), which could 
lead to an intensification of anxiety symptoms. 
Second, it may be that anxiety disorders precede infectious 
diseases. One explanation for this path would be that anxiety dis- 
orders are related to psychological disturbance and stress. Stress is 
associated with an increased cortisol secretion and may contribute 
to an immune function decline. An immune function decline in 
anxious subjects had been shown on a physiological level, namely 
in a reduction of chemotaxis, phagocytosis, and lymphoprolifer- 
ation (33). Alternatively, studies have shown that the extent and 
quality of general medical health care among those with mental 
disorders might be poor (31). Even though the association has 
mainly been shown in psychotic and substance use disorders (31), 
it may be that people with anxiety disorders receive less medical 
information and therefore the frequency of vaccination could be 
lower among these subjects leading to increased rates of some 
infectious diseases. 
Third, it may be that there is a common factor related to an 
increased risk of having both infectious diseases and anxiety dis- 
orders at the same time. Both genetic and environmental common 
factors could be considered. In our analyses, we found increased 
rates of  whooping cough, scarlet fever, dysentery, typhus, and !!
 !
FIGURE 2 | The association of anxiety disorders and infectious diseases and health-related quality  of life. Mean  scores adjusted for sex. 
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diphtheria in subjects with panic attacks. In prospective analy- 
ses, prior regular smoking was found to increase the risk of panic 
attacks (34). Smoking on the other hand increases the risk of bac- 
terial or viral infections (35). One might therefore speculate that 
smoking could act as a common environmental risk factor for both 
infectious diseases and mental disorders. 
Our results also show that individuals with both conditions 
have a loss in health-related quality of life. This is in line with ear- 
lier findings of those with anxiety disorders and chronic physical 
diseases reporting decreased health-related quality of life (15). Our 
analyses additionally show that infectious diseases are not associ- 
ated with a significantly lower quality of life if they appear alone 
when compared to people with neither condition. In combination 
with anxiety disorders, however, they are. Our results therefore 
extend previous findings and show that not only chronic physi- 
cal diseases, but – at least partly – well treatable and time-limited 
infections are related to lower quality of life in subjects with anxiety 
disorders. 
The current study has a number of limitations. First, the preva- 
lence rates of the infectious diseases are based on self-report. 
Therefore, it may be that some infectious diseases are misunder- 
stood (e.g., whooping cough may be confused to cough in general 
or may be overreported). Even though there is evidence suggest- 
ing that the validity of self-assessment of certain infectious diseases 
such as a common cold is high (36), it is additionally known that 
negative emotional style can be associated with an over-reporting 
of unverified symptoms (reporting bias) (37). This needs to be 
addressed in future studies by assessing infectious diseases with 
medical interview or by laboratory blood tests. Second, the com- 
bination of infectious diseases and anxiety disorder led to some 
small cell sizes, especially in tuberculosis, dysentery, typhus, and 
diphtheria. Third, due to the cross-sectional nature of the study, 
no conclusions can be drawn concerning the causal relationship 
of the observed associations. Fourth, the results cannot be gener- 
alized to subjects younger than 18 and older than 65 years. Fifth, 
we only had 12-month diagnoses for anxiety disorders (except for 
panic disorder), whereas infectious diseases were assessed over life- 
time. Future studies should address this issue by comparing both 
infectious diseases and anxiety disorders during the same time 
frame. Sixth, potential other confounders may play a role in the 
associations. 
With these limitations in mind, our study extends prior find- 
ings (14) about the association between infectious diseases and 
anxiety disorders. Our study suggests that adults with infectious 
diseases report higher prevalence rates of anxiety disorders and 
that this comorbidity is associated with a health-related loss in 
quality of life. Future longitudinal studies should clarify the tem- 
poral relationship of these disorders and evaluate the pathways 
contributing to this comorbidity with targeted psychological and 
immunological parameters. The health-related loss in quality of 
life could underline the importance of disease prevention (e.g., 
vaccination) in people with anxiety disorders as especially sub- 
jects with both infectious disease and anxiety disorder reported 
an impairment in quality of life. The associations additionally 
show that infectious diseases and anxiety disorders might increase 
the risk of having one another, and/or they might have common 
shared risk factors at least in subtypes. This research could initiate 
future research on the linkage of infectious diseases and anxiety 
disorders. !!
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